社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Aaronnz
IP属地:未知
+关注
帖子 · 27
帖子 · 27
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Aaronnz
Aaronnz
·
2021-12-22
King is wang lee Hom, Who’s the queen
看
2,029
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-11-22
My god
Is the Stock Market Going to Crash Again?
The next market crash is inevitable. Prepare while you can.
Is the Stock Market Going to Crash Again?
看
1,609
回复
评论
点赞
2
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-11-17
Yes
China Duty Free Gets HKEX Approval for $5 Billion Share Sale
(Bloomberg) -- China Tourism Group Duty Free Corp., the world’s largest travel retailer, has receive
China Duty Free Gets HKEX Approval for $5 Billion Share Sale
看
1,254
回复
评论
点赞
4
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-11-03
Hi
Toplines Before US Market Open on Tuesday
U.S. stock index futures mixed on Tuesday, pointing to a slight easing from record highs for Wall St
Toplines Before US Market Open on Tuesday
看
1,917
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-11-01
Wow
干货!复盘TFAAMG超级科技股的财报季操作!
@OptionPlus:
TFAAMG财报都发了,最强的无疑是宇宙神车,中年微软稳如老大哥,负面缠身的FB换名托底,今天小+来整体复盘一下财报和一些操作思路。 $特斯拉(TSLA)$ 财报好到要用拿着放大镜才能找到一点点隐忧。在全球芯片荒的背景下,特斯拉第三季度没有受到任何影响,是一点都没有,这就已经大大超了预期,体现了特斯拉超强的上下游一体化的供应链整合能力,说白了,就统统掌控在自己手中。特斯拉的盈利能力也不断增强,财务状态处于史上最好的时期。业绩是基础,真正让特斯拉跻身万亿美元俱乐部的驱动因子是赫兹那张10万辆Model3的订单,这相当于锁定特斯拉10%的年产能,订单总价高达42亿美元,写下特斯拉史上最大一笔订单,刺激特斯拉股价当天大涨12%一举破万亿。 复盘特斯拉的操作,我在900和1000通过备兑行权分别卖出的特斯拉的正股。如果仅看财报,比较符合我的预期,前期积累的涨幅比较大,当天表现并没有特别跳跃。但财报两天后,赫兹的订单是完全出乎预料,这个拉伸走出超级的short squeeze。因为特斯拉在财报前期涨很多,盘面上聚集了大量的空头,包括通过期权和正股做空的。卖出特斯拉没有后悔,没有办法对突然起来的利好预判,我已经开始继续卖put,等待继续接回来的机会。其实对于风险偏好高的朋友,特斯拉这种做单向买call或者买put是可以赚大钱的。但是个人属于风险偏好中性,不愿追涨杀跌的典型,所以我更愿意等待价格回归再买入,那么卖put就是最好的等待接盘方式。我觉得特斯拉从10月初750左右价格连涨近50%,各种指标都在超买区域有足够需要回调的空间,所以我愿意等待。目前选择卖11月19日780/750的put去等待接盘,因为黄金分割线0.618的位置大概在760多。由于连涨,通过期权做空或做保护
干货!复盘TFAAMG超级科技股的财报季操作!
看
3,163
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-10-05
rolling
A decade later, Steve Jobs is still paving Apple’s path to success
Time rolls forward, the past recedes, and it all starts to fade, doesn’t it? Ten years ago, Steve Jo
A decade later, Steve Jobs is still paving Apple’s path to success
看
2,014
回复
1
点赞
6
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-08-16
Wow
5 Game-Changing Stocks That Can Turn $250,000 Into $1 Million by 2030
These innovative companies can generate life-altering returns for patient investors.
5 Game-Changing Stocks That Can Turn $250,000 Into $1 Million by 2030
看
1,731
回复
评论
点赞
2
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-08-11
Tell me your opinion about this news...
5 Growth Stocks With 110% to 393% Upside, According to Wall Street
Analysts are calling for significant gains in these fast-paced stocks.
5 Growth Stocks With 110% to 393% Upside, According to Wall Street
看
743
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-08-11
Hi
5 Growth Stocks With 110% to 393% Upside, According to Wall Street
Analysts are calling for significant gains in these fast-paced stocks.
5 Growth Stocks With 110% to 393% Upside, According to Wall Street
看
1,449
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Aaronnz
Aaronnz
·
2021-08-06
Oh no
Hong Kong shares slip as virus, regulatory concerns weigh
Hang Seng index ends down 0.1%. China Enterprises index HSCE falls 0.25%. Property sector down 0.6%;
Hong Kong shares slip as virus, regulatory concerns weigh
看
993
回复
1
点赞
4
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3583727724427055","uuid":"3583727724427055","gmtCreate":1620635897317,"gmtModify":1620886277549,"name":"Aaronnz","pinyin":"aaronnz","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":17,"tweetSize":27,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.97%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.10","exceedPercentage":"60.86%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691878701,"gmtCreate":1640176372946,"gmtModify":1640176373157,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"King is wang lee Hom, Who’s the queen ","listText":"King is wang lee Hom, Who’s the queen ","text":"King is wang lee Hom, Who’s the queen","images":[{"img":"https://static.tigerbbs.com/96a18122205672211f16d17caddaaca0","width":"642","height":"1141"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691878701","isVote":1,"tweetType":1,"viewCount":2029,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":872727652,"gmtCreate":1637578850077,"gmtModify":1637578850077,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"My god","listText":"My god","text":"My god","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872727652","repostId":"2185826772","repostType":2,"repost":{"id":"2185826772","kind":"highlight","pubTimestamp":1637573760,"share":"https://ttm.financial/m/news/2185826772?lang=&edition=full","pubTime":"2021-11-22 17:36","market":"us","language":"en","title":"Is the Stock Market Going to Crash Again?","url":"https://stock-news.laohu8.com/highlight/detail?id=2185826772","media":"Motley Fool","summary":"The next market crash is inevitable. Prepare while you can.","content":"<p>The market will crash again. That is inevitable. The only real question is when will it happen?</p>\n<p>Let's be clear: there are <i>lots </i>of reasons to believe the market could crash soon. Skyrocketing inflation , stretched valuations , and a critical labor shortage each could pose risks to the market on their own. Put them all together in a situation like we have today, and the danger certainly seems to multiply.</p>\n<p>Just because the market <i>could </i>crash soon doesn't mean it <i>will</i>, however. If it somehow manages to keep climbing, would you really want to be sitting on the sidelines, watching the purchasing power of your money evaporate to inflation?</p>\n<p>That combination of factors makes now <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the toughest times in most of our investing lifetimes to know what the best course of action should be. That might actually mean that there is no <i>single </i>best path forward and that the right approach could be to build a balance across the five options discussed here.</p>\n<h2>No. 1: Get out of (expensive) debt</h2>\n<p>If the market's massive run has left you in the position where you <i>could </i>pay off your debts, maybe that provides a good opportunity to <i>actually </i>do so. If not your entire debt burden, perhaps you could pay off everything but your fixed-rate, low interest mortgage?</p>\n<p>It might seem crazy to pay off debt when interest rates are so low and the market has seen such huge recent rises, but that could very well be the best time to do so. After all, if interest rates rise, that could both increase your debt service costs <i>and </i>cause at least some of your stocks to drop, catching you with a double-whammy. When you add in the fact your debt service costs need to be paid even if your stocks are way down, you get a situation where reducing or eliminating debt looks like a smart move.</p>\n<h2>No. 2: Build a cash buffer</h2>\n<p>In a world where inflation is running over 6%, having a lot of cash sitting around earning less than 1% might seem crazy. When viewed only on that basis, it is. When you recognize that market crashes and job losses often go hand in hand, having a decent cash buffer can be viewed as an insurance policy. At least for a little while, it can keep you from being forced to sell at the low due to lost income and buy you time to find alternatives.</p>\n<p>That said, with inflation running as hot as it is and cash returns failing to keep up, it might not be a good idea to hold too much cash. As a result, consider the standard guidance of three-to-six months' worth of basic living expenses as a reasonable \"goldilocks\" target.</p>\n<h2>No. 3: Plan for the big expenses coming your way soon</h2>\n<p>As a general rule, money you expect to spend within the next five years does not belong in stocks. If you have a big purchase coming up in that time window -- say a new car, a child's college education, or a bucket list vacation -- a market sitting near all-time highs can give you a great opportunity to sell.</p>\n<p>It's OK to sell enough stock to cover the costs of what you're buying in that window and any taxes you'll owe on your stock sale. Then, put the remaining money in something like a CD or Treasury or investment grade bonds that mature just before you'll need the money.</p>\n<p>No, you won't make stupendously high returns on that money, but you will also sleep more soundly knowing that a mere market crash won't automatically derail your near-term plans for that cash.</p>\n<h2>No. 4: Know a decent estimate of the value of what you own</h2>\n<p>Ultimately, stocks are nothing more than fractional ownership stakes in companies. Yes, their market prices can rise or fall a whole bunch in a very short period of time, but in the long run, stocks are tied to the cash generating capability of the businesses behind those shares.</p>\n<p>Using the discounted cash flow model and reasonable projections for the future of the company, you can estimate what that fair value would be. You can easily adjust your assumptions for a more aggressive growth future or a more pessimistic one as well, to get a feel for a range of potential values. You can then compare your model with the market's price and use that to inform your buy, sell, or hold decisions.</p>\n<p>If a company you own is priced so high by the market that even your most aggressive estimates for its future can't keep up, then it might be a good idea to sell it. On the flip side, if a company you own is available for such a dirt cheap price that even your pessimistic estimate is above the market's price for it, you might want to consider buying even more.</p>\n<p>The beauty of the discounted cash flow model is that it can help you make those buy/sell/hold decisions regardless of what the overall market is doing. As a result, it can help you both prepare for a crash by figuring out which companies to consider selling and invest through a crash by figuring out which ones are the biggest bargains worthy of buying.</p>\n<h2>No. 5: Invest with the long term in mind</h2>\n<p>With the first three options, you've taken great steps to protect yourself against many of the short term disruptions that can come from market crashes. With the fourth option, you've given yourself a tool to make smarter investing decisions around the time of a crash. Together, they free you up to truly have a long-term perspective when you invest in stocks.</p>\n<p>That long-term perspective is important because it provides the foundation of the biggest advantage you have against Wall Street: your patience. With a long-term perspective, the rest of your financial house in order, and decent valuations at your disposal, you can stay invested during and after a crash. That is absolutely key to being invested during any subsequent recovery, which is where the next round of wealth can be built.</p>\n<h2>Get ready now for the next crash</h2>\n<p>None of us really know when the next stock market crash will happen, but we can be pretty sure that there will be another one headed our way. With the market near all-time highs and so many very clear economic risks in front of us, now could be a great time to make the adjustments you need to get prepared for that crash.</p>\n<p>By balancing the tools you need to survive the next crash with a long term perspective for the money you're able to keep invested, you can be prepared no matter when that crash takes place. Get yourself ready now, and you will have the advantage of being ready before it happens, rather than trying to clean up after the fact.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is the Stock Market Going to Crash Again?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs the Stock Market Going to Crash Again?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-22 17:36 GMT+8 <a href=https://www.fool.com/investing/2021/11/21/is-the-stock-market-going-to-crash-again/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The market will crash again. That is inevitable. The only real question is when will it happen?\nLet's be clear: there are lots of reasons to believe the market could crash soon. Skyrocketing inflation...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/21/is-the-stock-market-going-to-crash-again/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.fool.com/investing/2021/11/21/is-the-stock-market-going-to-crash-again/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185826772","content_text":"The market will crash again. That is inevitable. The only real question is when will it happen?\nLet's be clear: there are lots of reasons to believe the market could crash soon. Skyrocketing inflation , stretched valuations , and a critical labor shortage each could pose risks to the market on their own. Put them all together in a situation like we have today, and the danger certainly seems to multiply.\nJust because the market could crash soon doesn't mean it will, however. If it somehow manages to keep climbing, would you really want to be sitting on the sidelines, watching the purchasing power of your money evaporate to inflation?\nThat combination of factors makes now one of the toughest times in most of our investing lifetimes to know what the best course of action should be. That might actually mean that there is no single best path forward and that the right approach could be to build a balance across the five options discussed here.\nNo. 1: Get out of (expensive) debt\nIf the market's massive run has left you in the position where you could pay off your debts, maybe that provides a good opportunity to actually do so. If not your entire debt burden, perhaps you could pay off everything but your fixed-rate, low interest mortgage?\nIt might seem crazy to pay off debt when interest rates are so low and the market has seen such huge recent rises, but that could very well be the best time to do so. After all, if interest rates rise, that could both increase your debt service costs and cause at least some of your stocks to drop, catching you with a double-whammy. When you add in the fact your debt service costs need to be paid even if your stocks are way down, you get a situation where reducing or eliminating debt looks like a smart move.\nNo. 2: Build a cash buffer\nIn a world where inflation is running over 6%, having a lot of cash sitting around earning less than 1% might seem crazy. When viewed only on that basis, it is. When you recognize that market crashes and job losses often go hand in hand, having a decent cash buffer can be viewed as an insurance policy. At least for a little while, it can keep you from being forced to sell at the low due to lost income and buy you time to find alternatives.\nThat said, with inflation running as hot as it is and cash returns failing to keep up, it might not be a good idea to hold too much cash. As a result, consider the standard guidance of three-to-six months' worth of basic living expenses as a reasonable \"goldilocks\" target.\nNo. 3: Plan for the big expenses coming your way soon\nAs a general rule, money you expect to spend within the next five years does not belong in stocks. If you have a big purchase coming up in that time window -- say a new car, a child's college education, or a bucket list vacation -- a market sitting near all-time highs can give you a great opportunity to sell.\nIt's OK to sell enough stock to cover the costs of what you're buying in that window and any taxes you'll owe on your stock sale. Then, put the remaining money in something like a CD or Treasury or investment grade bonds that mature just before you'll need the money.\nNo, you won't make stupendously high returns on that money, but you will also sleep more soundly knowing that a mere market crash won't automatically derail your near-term plans for that cash.\nNo. 4: Know a decent estimate of the value of what you own\nUltimately, stocks are nothing more than fractional ownership stakes in companies. Yes, their market prices can rise or fall a whole bunch in a very short period of time, but in the long run, stocks are tied to the cash generating capability of the businesses behind those shares.\nUsing the discounted cash flow model and reasonable projections for the future of the company, you can estimate what that fair value would be. You can easily adjust your assumptions for a more aggressive growth future or a more pessimistic one as well, to get a feel for a range of potential values. You can then compare your model with the market's price and use that to inform your buy, sell, or hold decisions.\nIf a company you own is priced so high by the market that even your most aggressive estimates for its future can't keep up, then it might be a good idea to sell it. On the flip side, if a company you own is available for such a dirt cheap price that even your pessimistic estimate is above the market's price for it, you might want to consider buying even more.\nThe beauty of the discounted cash flow model is that it can help you make those buy/sell/hold decisions regardless of what the overall market is doing. As a result, it can help you both prepare for a crash by figuring out which companies to consider selling and invest through a crash by figuring out which ones are the biggest bargains worthy of buying.\nNo. 5: Invest with the long term in mind\nWith the first three options, you've taken great steps to protect yourself against many of the short term disruptions that can come from market crashes. With the fourth option, you've given yourself a tool to make smarter investing decisions around the time of a crash. Together, they free you up to truly have a long-term perspective when you invest in stocks.\nThat long-term perspective is important because it provides the foundation of the biggest advantage you have against Wall Street: your patience. With a long-term perspective, the rest of your financial house in order, and decent valuations at your disposal, you can stay invested during and after a crash. That is absolutely key to being invested during any subsequent recovery, which is where the next round of wealth can be built.\nGet ready now for the next crash\nNone of us really know when the next stock market crash will happen, but we can be pretty sure that there will be another one headed our way. With the market near all-time highs and so many very clear economic risks in front of us, now could be a great time to make the adjustments you need to get prepared for that crash.\nBy balancing the tools you need to survive the next crash with a long term perspective for the money you're able to keep invested, you can be prepared no matter when that crash takes place. Get yourself ready now, and you will have the advantage of being ready before it happens, rather than trying to clean up after the fact.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1609,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878005651,"gmtCreate":1637119110653,"gmtModify":1637119670459,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878005651","repostId":"1197815029","repostType":2,"repost":{"id":"1197815029","kind":"news","pubTimestamp":1637118433,"share":"https://ttm.financial/m/news/1197815029?lang=&edition=full","pubTime":"2021-11-17 11:07","market":"sh","language":"en","title":"China Duty Free Gets HKEX Approval for $5 Billion Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1197815029","media":"Bloomberg","summary":"(Bloomberg) -- China Tourism Group Duty Free Corp., the world’s largest travel retailer, has receive","content":"<p>(Bloomberg) -- China Tourism Group Duty Free Corp., the world’s largest travel retailer, has received permission from the Hong Kong stock exchange to proceed with a share sale in Asia’s financial hub, according to people familiar with the matter.</p>\n<p>The offering by the state-owned operator of duty-free businesses across China, Hong Kong, Macau and some Southeast Asian cities could raise about $5 billion, one of the people said, asking not to be identified as the information is private.</p>\n<p>The company’s Shanghai shares fell as much as 1.9% on Wednesday. The Beijing-based firm’s stock has slumped about 40% from its Feb. 10 record, giving it a market value of about $71 billion.</p>\n<p>IFR first reported the outcome of the hearing. A representative for CTG Duty Free declined to comment, while a spokesperson for Hong Kong Exchanges & Clearing Ltd. said they can’t comment on individual companies.</p>\n<p>At $5 billion, the IPO would be this year’s second biggest in Hong Kong, after Chinese short-video company Kuaishou Technology’s initial public offering which raised $6.2 billion in the first quarter, according to data compiled by Bloomberg.</p>\n<p>Founded in 1984, China Tourism Group Duty Free has established over 240 retail stores in China and abroad, according to its website. It filed an overseas listing application with the China Securities Regulatory Commission in June and got the regulator’s approval last week.</p>\n<p>China International Capital Corp. and UBS Group AG are the joint sponsors of the Hong Kong listing, according to a preliminary prospectus.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Duty Free Gets HKEX Approval for $5 Billion Share Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Duty Free Gets HKEX Approval for $5 Billion Share Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-17 11:07 GMT+8 <a href=https://finance.yahoo.com/news/china-duty-free-gets-hkex-022619061.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- China Tourism Group Duty Free Corp., the world’s largest travel retailer, has received permission from the Hong Kong stock exchange to proceed with a share sale in Asia’s financial hub,...</p>\n\n<a href=\"https://finance.yahoo.com/news/china-duty-free-gets-hkex-022619061.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"601888":"中国中免"},"source_url":"https://finance.yahoo.com/news/china-duty-free-gets-hkex-022619061.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197815029","content_text":"(Bloomberg) -- China Tourism Group Duty Free Corp., the world’s largest travel retailer, has received permission from the Hong Kong stock exchange to proceed with a share sale in Asia’s financial hub, according to people familiar with the matter.\nThe offering by the state-owned operator of duty-free businesses across China, Hong Kong, Macau and some Southeast Asian cities could raise about $5 billion, one of the people said, asking not to be identified as the information is private.\nThe company’s Shanghai shares fell as much as 1.9% on Wednesday. The Beijing-based firm’s stock has slumped about 40% from its Feb. 10 record, giving it a market value of about $71 billion.\nIFR first reported the outcome of the hearing. A representative for CTG Duty Free declined to comment, while a spokesperson for Hong Kong Exchanges & Clearing Ltd. said they can’t comment on individual companies.\nAt $5 billion, the IPO would be this year’s second biggest in Hong Kong, after Chinese short-video company Kuaishou Technology’s initial public offering which raised $6.2 billion in the first quarter, according to data compiled by Bloomberg.\nFounded in 1984, China Tourism Group Duty Free has established over 240 retail stores in China and abroad, according to its website. It filed an overseas listing application with the China Securities Regulatory Commission in June and got the regulator’s approval last week.\nChina International Capital Corp. and UBS Group AG are the joint sponsors of the Hong Kong listing, according to a preliminary prospectus.","news_type":1,"symbols_score_info":{"601888":0.9}},"isVote":1,"tweetType":1,"viewCount":1254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841260751,"gmtCreate":1635915465344,"gmtModify":1635915465423,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841260751","repostId":"1147199832","repostType":2,"repost":{"id":"1147199832","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635855008,"share":"https://ttm.financial/m/news/1147199832?lang=&edition=full","pubTime":"2021-11-02 20:10","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1147199832","media":"Tiger Newspress","summary":"U.S. stock index futures mixed on Tuesday, pointing to a slight easing from record highs for Wall St","content":"<p>U.S. stock index futures mixed on Tuesday, pointing to a slight easing from record highs for Wall Street indexes as investors took to caution ahead of the Federal Reserve’s widely expected move to start tapering its monthly bond purchases.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 29 points, or 0.08%, S&P 500 e-minis were up 2 points, or 0.04%, and Nasdaq 100 e-minis were down 17.5 points, or 0.1%.</p>\n<p><img src=\"https://static.tigerbbs.com/6e516df5a8317319822c86b104fb50dd\" tg-width=\"1080\" tg-height=\"378\" width=\"100%\" height=\"auto\"></p>\n<p>The U.S. central bank on Wednesday is expected to approve plans to scale back its pandemic-era support for the world’s largest economy, while focus will also be on commentary about interest rates and how sustained the recent surge in inflation is.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Tesla(TSLA)</b> – Tesla stock fell 4.6% in premarket trading.Reports of recalls and Hertz-deal uncertainties are two reasons the stock might be down.</p>\n<p><b>Pfizer</b><b>(PFE)</b> – Pfizer jumped 2.8% in the premarket after the drugmaker reported better-than-expected profit and revenue for the third quarter. Pfizer earned $1.34 per share, 25 cents a share above estimates. The company also issued an improved full-year forecast on strong demand for both its Covid-19 vaccine and non-Covid treatments.</p>\n<p><b>Novavax(</b><b>NVAX</b><b>)</b> – Novavax shares jumped another 4% in premarket trading Tuesday after rising nearly 16% yesterday as Novavax COVID-19 vaccine got first authorization; expected more within weeks.</p>\n<p><b>Lucid(LCID)</b> – ucid stock fell 4.5% in premarket trading.Morgan Stanley thinks shares are significantly overvalued at current levels and rates LCID as Underweight (i.e. Sell),backed by a $12 price target. This figure suggests shares will lose a huge 67% of their value over the next 12 months.</p>\n<p><b>ConocoPhillips(COP)</b> – ConocoPhillips stock rose nearly 1% after the oil company reported better-than-expected earnings.Conoco reported an adjusted profit of $1.77 a share, beating forecasts for $1.50 a share.Conoco credited not just rising oil prices for the earnings beat, but also progress in integrating Concho Resources, which agreed to buy in October 2020.</p>\n<p><b>Under Armour</b><b>(UAA) </b>– The athletic apparel maker’s shares surged 9.5% in premarket trading after it more than doubled the 15 cents a share consensus estimate, with quarterly earnings of 31 cents per share. Under Armour also raised its full-year outlook, as consumers maintain a high interest in comfortable daily wear.</p>\n<p><b>Generac(GNRC)</b> – Generac shares slid 4.9% in the premarket after beating bottom-line estimates but reporting lower-than-expected quarterly sales. Separately, the maker of home and commercial generators announced it is buying Canada-based smart thermostat maker Ecobee in a cash-and-stock deal that could be worth up to $770 million, depending on whether Ecobee reaches certain performance targets.</p>\n<p><b>DuPont(DD) </b>– DuPont rose 1.1% in premarket action after the chemical maker beat estimates but cut its full-year outlook citing decelerating orders from customers due to the worldwide chip shortage. DuPont came in 3 cents a share above estimates, with third-quarter profit of $1.15 per share. Separately, DuPont announced the acquisition of materials technology company <b>Rogers Corp.(ROG)</b> in a $5.2 billion deal, with Rogers soaring 27.3% following news of the deal.</p>\n<p><b>Estee Lauder(EL)</b> – The cosmetics maker’s stock dropped 2.5% in the premarket, as it beat Street forecasts but cut its annual sales outlook due to inflation and supply chain disruptions. Estee Lauder earned $1.86 per share for the quarter, compared to a $1.70 share consensus estimate.</p>\n<p><b>Avis Budget(CAR)</b> – Avis Budget reported quarterly earnings of $10.74 per share, well above the $6.52 a share consensus estimate. Revenue also topped Wall Street forecasts. Heavy demand for rental cars and higher rental rates gave a significant boost to Avis Budget’s results. The stock rallied 6.6% in premarket trading.</p>\n<p><b>Simon Property(SPG)</b> – Simon nearly doubled the $1.09 per share consensus estimate, with quarterly earnings of $2.07 per share. The mall operator’s revenue also came in above analysts’ projections. Simon saw improved occupancy rates for its shopping malls during the quarter as well as an increase in shopper traffic. Simon shares rallied 4.2% in premarket action.</p>\n<p><b>Clorox(CLX)</b> – Clorox beat estimates by 18 cents a share, with quarterly earnings of $1.21 per share. The household products maker posted better-than-expected revenue as well, and Clorox backed its prior full-year forecast. Its stock was up 2.2% in the premarket.</p>\n<p><b>Chegg(CHGG)</b> – Chegg shares tanked 33% in the premarket after the online education company reported lower-than-expected quarterly sales and merely matched Street estimates, with quarterly earnings of 20 cents per share. Chegg said enrollment did not bounce back as it had expected.</p>\n<p><b>Nutrien(NTR)</b> – Nutrien raised its full-year profit outlook, amid strong global demand and higher prices for the Canadian fertilizer maker’s products.</p>\n<p><b>McKesson(MCK)</b> – The drug distributor earned $6.15 per share for its latest quarter, easily beating the consensus estimate of $4.66 a share. Revenue topping estimates as well, driven by strong delivery numbers for more expensive specialty drugs as well as its government contract to distribute Covid-19 vaccines. McKesson shares gained 3.4% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-02 20:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures mixed on Tuesday, pointing to a slight easing from record highs for Wall Street indexes as investors took to caution ahead of the Federal Reserve’s widely expected move to start tapering its monthly bond purchases.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 29 points, or 0.08%, S&P 500 e-minis were up 2 points, or 0.04%, and Nasdaq 100 e-minis were down 17.5 points, or 0.1%.</p>\n<p><img src=\"https://static.tigerbbs.com/6e516df5a8317319822c86b104fb50dd\" tg-width=\"1080\" tg-height=\"378\" width=\"100%\" height=\"auto\"></p>\n<p>The U.S. central bank on Wednesday is expected to approve plans to scale back its pandemic-era support for the world’s largest economy, while focus will also be on commentary about interest rates and how sustained the recent surge in inflation is.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Tesla(TSLA)</b> – Tesla stock fell 4.6% in premarket trading.Reports of recalls and Hertz-deal uncertainties are two reasons the stock might be down.</p>\n<p><b>Pfizer</b><b>(PFE)</b> – Pfizer jumped 2.8% in the premarket after the drugmaker reported better-than-expected profit and revenue for the third quarter. Pfizer earned $1.34 per share, 25 cents a share above estimates. The company also issued an improved full-year forecast on strong demand for both its Covid-19 vaccine and non-Covid treatments.</p>\n<p><b>Novavax(</b><b>NVAX</b><b>)</b> – Novavax shares jumped another 4% in premarket trading Tuesday after rising nearly 16% yesterday as Novavax COVID-19 vaccine got first authorization; expected more within weeks.</p>\n<p><b>Lucid(LCID)</b> – ucid stock fell 4.5% in premarket trading.Morgan Stanley thinks shares are significantly overvalued at current levels and rates LCID as Underweight (i.e. Sell),backed by a $12 price target. This figure suggests shares will lose a huge 67% of their value over the next 12 months.</p>\n<p><b>ConocoPhillips(COP)</b> – ConocoPhillips stock rose nearly 1% after the oil company reported better-than-expected earnings.Conoco reported an adjusted profit of $1.77 a share, beating forecasts for $1.50 a share.Conoco credited not just rising oil prices for the earnings beat, but also progress in integrating Concho Resources, which agreed to buy in October 2020.</p>\n<p><b>Under Armour</b><b>(UAA) </b>– The athletic apparel maker’s shares surged 9.5% in premarket trading after it more than doubled the 15 cents a share consensus estimate, with quarterly earnings of 31 cents per share. Under Armour also raised its full-year outlook, as consumers maintain a high interest in comfortable daily wear.</p>\n<p><b>Generac(GNRC)</b> – Generac shares slid 4.9% in the premarket after beating bottom-line estimates but reporting lower-than-expected quarterly sales. Separately, the maker of home and commercial generators announced it is buying Canada-based smart thermostat maker Ecobee in a cash-and-stock deal that could be worth up to $770 million, depending on whether Ecobee reaches certain performance targets.</p>\n<p><b>DuPont(DD) </b>– DuPont rose 1.1% in premarket action after the chemical maker beat estimates but cut its full-year outlook citing decelerating orders from customers due to the worldwide chip shortage. DuPont came in 3 cents a share above estimates, with third-quarter profit of $1.15 per share. Separately, DuPont announced the acquisition of materials technology company <b>Rogers Corp.(ROG)</b> in a $5.2 billion deal, with Rogers soaring 27.3% following news of the deal.</p>\n<p><b>Estee Lauder(EL)</b> – The cosmetics maker’s stock dropped 2.5% in the premarket, as it beat Street forecasts but cut its annual sales outlook due to inflation and supply chain disruptions. Estee Lauder earned $1.86 per share for the quarter, compared to a $1.70 share consensus estimate.</p>\n<p><b>Avis Budget(CAR)</b> – Avis Budget reported quarterly earnings of $10.74 per share, well above the $6.52 a share consensus estimate. Revenue also topped Wall Street forecasts. Heavy demand for rental cars and higher rental rates gave a significant boost to Avis Budget’s results. The stock rallied 6.6% in premarket trading.</p>\n<p><b>Simon Property(SPG)</b> – Simon nearly doubled the $1.09 per share consensus estimate, with quarterly earnings of $2.07 per share. The mall operator’s revenue also came in above analysts’ projections. Simon saw improved occupancy rates for its shopping malls during the quarter as well as an increase in shopper traffic. Simon shares rallied 4.2% in premarket action.</p>\n<p><b>Clorox(CLX)</b> – Clorox beat estimates by 18 cents a share, with quarterly earnings of $1.21 per share. The household products maker posted better-than-expected revenue as well, and Clorox backed its prior full-year forecast. Its stock was up 2.2% in the premarket.</p>\n<p><b>Chegg(CHGG)</b> – Chegg shares tanked 33% in the premarket after the online education company reported lower-than-expected quarterly sales and merely matched Street estimates, with quarterly earnings of 20 cents per share. Chegg said enrollment did not bounce back as it had expected.</p>\n<p><b>Nutrien(NTR)</b> – Nutrien raised its full-year profit outlook, amid strong global demand and higher prices for the Canadian fertilizer maker’s products.</p>\n<p><b>McKesson(MCK)</b> – The drug distributor earned $6.15 per share for its latest quarter, easily beating the consensus estimate of $4.66 a share. Revenue topping estimates as well, driven by strong delivery numbers for more expensive specialty drugs as well as its government contract to distribute Covid-19 vaccines. McKesson shares gained 3.4% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EL":"雅诗兰黛","DD":"杜邦","ROG":"罗杰斯","UAA":"安德玛公司A类股","NVAX":"诺瓦瓦克斯医药","CAR":"安飞士","NTR":"Nutrien Ltd.","GNRC":"Generac控股",".SPX":"S&P 500 Index","PFE":"辉瑞",".IXIC":"NASDAQ Composite","MCK":"麦克森药物批发","CLX":"高乐氏","COP":"康菲石油",".DJI":"道琼斯","TSLA":"特斯拉","CHGG":"Chegg Inc","LCID":"Lucid Group Inc","SPG":"西蒙地产"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147199832","content_text":"U.S. stock index futures mixed on Tuesday, pointing to a slight easing from record highs for Wall Street indexes as investors took to caution ahead of the Federal Reserve’s widely expected move to start tapering its monthly bond purchases.\nAt 8:00 a.m. ET, Dow e-minis were up 29 points, or 0.08%, S&P 500 e-minis were up 2 points, or 0.04%, and Nasdaq 100 e-minis were down 17.5 points, or 0.1%.\n\nThe U.S. central bank on Wednesday is expected to approve plans to scale back its pandemic-era support for the world’s largest economy, while focus will also be on commentary about interest rates and how sustained the recent surge in inflation is.\nStocks making the biggest moves in the premarket:\nTesla(TSLA) – Tesla stock fell 4.6% in premarket trading.Reports of recalls and Hertz-deal uncertainties are two reasons the stock might be down.\nPfizer(PFE) – Pfizer jumped 2.8% in the premarket after the drugmaker reported better-than-expected profit and revenue for the third quarter. Pfizer earned $1.34 per share, 25 cents a share above estimates. The company also issued an improved full-year forecast on strong demand for both its Covid-19 vaccine and non-Covid treatments.\nNovavax(NVAX) – Novavax shares jumped another 4% in premarket trading Tuesday after rising nearly 16% yesterday as Novavax COVID-19 vaccine got first authorization; expected more within weeks.\nLucid(LCID) – ucid stock fell 4.5% in premarket trading.Morgan Stanley thinks shares are significantly overvalued at current levels and rates LCID as Underweight (i.e. Sell),backed by a $12 price target. This figure suggests shares will lose a huge 67% of their value over the next 12 months.\nConocoPhillips(COP) – ConocoPhillips stock rose nearly 1% after the oil company reported better-than-expected earnings.Conoco reported an adjusted profit of $1.77 a share, beating forecasts for $1.50 a share.Conoco credited not just rising oil prices for the earnings beat, but also progress in integrating Concho Resources, which agreed to buy in October 2020.\nUnder Armour(UAA) – The athletic apparel maker’s shares surged 9.5% in premarket trading after it more than doubled the 15 cents a share consensus estimate, with quarterly earnings of 31 cents per share. Under Armour also raised its full-year outlook, as consumers maintain a high interest in comfortable daily wear.\nGenerac(GNRC) – Generac shares slid 4.9% in the premarket after beating bottom-line estimates but reporting lower-than-expected quarterly sales. Separately, the maker of home and commercial generators announced it is buying Canada-based smart thermostat maker Ecobee in a cash-and-stock deal that could be worth up to $770 million, depending on whether Ecobee reaches certain performance targets.\nDuPont(DD) – DuPont rose 1.1% in premarket action after the chemical maker beat estimates but cut its full-year outlook citing decelerating orders from customers due to the worldwide chip shortage. DuPont came in 3 cents a share above estimates, with third-quarter profit of $1.15 per share. Separately, DuPont announced the acquisition of materials technology company Rogers Corp.(ROG) in a $5.2 billion deal, with Rogers soaring 27.3% following news of the deal.\nEstee Lauder(EL) – The cosmetics maker’s stock dropped 2.5% in the premarket, as it beat Street forecasts but cut its annual sales outlook due to inflation and supply chain disruptions. Estee Lauder earned $1.86 per share for the quarter, compared to a $1.70 share consensus estimate.\nAvis Budget(CAR) – Avis Budget reported quarterly earnings of $10.74 per share, well above the $6.52 a share consensus estimate. Revenue also topped Wall Street forecasts. Heavy demand for rental cars and higher rental rates gave a significant boost to Avis Budget’s results. The stock rallied 6.6% in premarket trading.\nSimon Property(SPG) – Simon nearly doubled the $1.09 per share consensus estimate, with quarterly earnings of $2.07 per share. The mall operator’s revenue also came in above analysts’ projections. Simon saw improved occupancy rates for its shopping malls during the quarter as well as an increase in shopper traffic. Simon shares rallied 4.2% in premarket action.\nClorox(CLX) – Clorox beat estimates by 18 cents a share, with quarterly earnings of $1.21 per share. The household products maker posted better-than-expected revenue as well, and Clorox backed its prior full-year forecast. Its stock was up 2.2% in the premarket.\nChegg(CHGG) – Chegg shares tanked 33% in the premarket after the online education company reported lower-than-expected quarterly sales and merely matched Street estimates, with quarterly earnings of 20 cents per share. Chegg said enrollment did not bounce back as it had expected.\nNutrien(NTR) – Nutrien raised its full-year profit outlook, amid strong global demand and higher prices for the Canadian fertilizer maker’s products.\nMcKesson(MCK) – The drug distributor earned $6.15 per share for its latest quarter, easily beating the consensus estimate of $4.66 a share. Revenue topping estimates as well, driven by strong delivery numbers for more expensive specialty drugs as well as its government contract to distribute Covid-19 vaccines. McKesson shares gained 3.4% in the premarket.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"CAR":0.9,"CHGG":0.9,"CLX":0.9,"COP":0.9,"DD":0.9,"EL":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"GNRC":0.9,"LCID":0.9,"MCK":0.9,"NTR":0.9,"NVAX":0.9,"PFE":0.9,"ROG":0.9,"SPG":0.9,"TSLA":0.9,"UAA":0.9}},"isVote":1,"tweetType":1,"viewCount":1917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849614480,"gmtCreate":1635751634652,"gmtModify":1635751634652,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849614480","repostId":"840765112","repostType":1,"repost":{"id":840765112,"gmtCreate":1635690618732,"gmtModify":1635691807046,"author":{"id":"3527667591235607","authorId":"3527667591235607","name":"OptionPlus","avatar":"https://static.tigerbbs.com/e8009c23927adcf8b5e1e1d101178392","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667591235607","idStr":"3527667591235607"},"themes":[],"title":"干货!复盘TFAAMG超级科技股的财报季操作!","htmlText":"TFAAMG财报都发了,最强的无疑是宇宙神车,中年微软稳如老大哥,负面缠身的FB换名托底,今天小+来整体复盘一下财报和一些操作思路。 <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 财报好到要用拿着放大镜才能找到一点点隐忧。在全球芯片荒的背景下,特斯拉第三季度没有受到任何影响,是一点都没有,这就已经大大超了预期,体现了特斯拉超强的上下游一体化的供应链整合能力,说白了,就统统掌控在自己手中。特斯拉的盈利能力也不断增强,财务状态处于史上最好的时期。业绩是基础,真正让特斯拉跻身万亿美元俱乐部的驱动因子是赫兹那张10万辆Model3的订单,这相当于锁定特斯拉10%的年产能,订单总价高达42亿美元,写下特斯拉史上最大一笔订单,刺激特斯拉股价当天大涨12%一举破万亿。 复盘特斯拉的操作,我在900和1000通过备兑行权分别卖出的特斯拉的正股。如果仅看财报,比较符合我的预期,前期积累的涨幅比较大,当天表现并没有特别跳跃。但财报两天后,赫兹的订单是完全出乎预料,这个拉伸走出超级的short squeeze。因为特斯拉在财报前期涨很多,盘面上聚集了大量的空头,包括通过期权和正股做空的。卖出特斯拉没有后悔,没有办法对突然起来的利好预判,我已经开始继续卖put,等待继续接回来的机会。其实对于风险偏好高的朋友,特斯拉这种做单向买call或者买put是可以赚大钱的。但是个人属于风险偏好中性,不愿追涨杀跌的典型,所以我更愿意等待价格回归再买入,那么卖put就是最好的等待接盘方式。我觉得特斯拉从10月初750左右价格连涨近50%,各种指标都在超买区域有足够需要回调的空间,所以我愿意等待。目前选择卖11月19日780/750的put去等待接盘,因为黄金分割线0.618的位置大概在760多。由于连涨,通过期权做空或做保护","listText":"TFAAMG财报都发了,最强的无疑是宇宙神车,中年微软稳如老大哥,负面缠身的FB换名托底,今天小+来整体复盘一下财报和一些操作思路。 <a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> 财报好到要用拿着放大镜才能找到一点点隐忧。在全球芯片荒的背景下,特斯拉第三季度没有受到任何影响,是一点都没有,这就已经大大超了预期,体现了特斯拉超强的上下游一体化的供应链整合能力,说白了,就统统掌控在自己手中。特斯拉的盈利能力也不断增强,财务状态处于史上最好的时期。业绩是基础,真正让特斯拉跻身万亿美元俱乐部的驱动因子是赫兹那张10万辆Model3的订单,这相当于锁定特斯拉10%的年产能,订单总价高达42亿美元,写下特斯拉史上最大一笔订单,刺激特斯拉股价当天大涨12%一举破万亿。 复盘特斯拉的操作,我在900和1000通过备兑行权分别卖出的特斯拉的正股。如果仅看财报,比较符合我的预期,前期积累的涨幅比较大,当天表现并没有特别跳跃。但财报两天后,赫兹的订单是完全出乎预料,这个拉伸走出超级的short squeeze。因为特斯拉在财报前期涨很多,盘面上聚集了大量的空头,包括通过期权和正股做空的。卖出特斯拉没有后悔,没有办法对突然起来的利好预判,我已经开始继续卖put,等待继续接回来的机会。其实对于风险偏好高的朋友,特斯拉这种做单向买call或者买put是可以赚大钱的。但是个人属于风险偏好中性,不愿追涨杀跌的典型,所以我更愿意等待价格回归再买入,那么卖put就是最好的等待接盘方式。我觉得特斯拉从10月初750左右价格连涨近50%,各种指标都在超买区域有足够需要回调的空间,所以我愿意等待。目前选择卖11月19日780/750的put去等待接盘,因为黄金分割线0.618的位置大概在760多。由于连涨,通过期权做空或做保护","text":"TFAAMG财报都发了,最强的无疑是宇宙神车,中年微软稳如老大哥,负面缠身的FB换名托底,今天小+来整体复盘一下财报和一些操作思路。 $特斯拉(TSLA)$ 财报好到要用拿着放大镜才能找到一点点隐忧。在全球芯片荒的背景下,特斯拉第三季度没有受到任何影响,是一点都没有,这就已经大大超了预期,体现了特斯拉超强的上下游一体化的供应链整合能力,说白了,就统统掌控在自己手中。特斯拉的盈利能力也不断增强,财务状态处于史上最好的时期。业绩是基础,真正让特斯拉跻身万亿美元俱乐部的驱动因子是赫兹那张10万辆Model3的订单,这相当于锁定特斯拉10%的年产能,订单总价高达42亿美元,写下特斯拉史上最大一笔订单,刺激特斯拉股价当天大涨12%一举破万亿。 复盘特斯拉的操作,我在900和1000通过备兑行权分别卖出的特斯拉的正股。如果仅看财报,比较符合我的预期,前期积累的涨幅比较大,当天表现并没有特别跳跃。但财报两天后,赫兹的订单是完全出乎预料,这个拉伸走出超级的short squeeze。因为特斯拉在财报前期涨很多,盘面上聚集了大量的空头,包括通过期权和正股做空的。卖出特斯拉没有后悔,没有办法对突然起来的利好预判,我已经开始继续卖put,等待继续接回来的机会。其实对于风险偏好高的朋友,特斯拉这种做单向买call或者买put是可以赚大钱的。但是个人属于风险偏好中性,不愿追涨杀跌的典型,所以我更愿意等待价格回归再买入,那么卖put就是最好的等待接盘方式。我觉得特斯拉从10月初750左右价格连涨近50%,各种指标都在超买区域有足够需要回调的空间,所以我愿意等待。目前选择卖11月19日780/750的put去等待接盘,因为黄金分割线0.618的位置大概在760多。由于连涨,通过期权做空或做保护","images":[{"img":"https://static.tigerbbs.com/f52b4e657cd48e8efa515ccee6db1d3e","width":"830","height":"604"},{"img":"https://static.tigerbbs.com/ca1db6c9b9b1761f1cc1f1708a57e335","width":"830","height":"318"},{"img":"https://static.tigerbbs.com/bb5e7a5788bee29f7249de462502c00f","width":"830","height":"600"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840765112","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":9,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829028580,"gmtCreate":1633444242901,"gmtModify":1633444243051,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"rolling","listText":"rolling","text":"rolling","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829028580","repostId":"1116662375","repostType":4,"repost":{"id":"1116662375","kind":"news","pubTimestamp":1633441259,"share":"https://ttm.financial/m/news/1116662375?lang=&edition=full","pubTime":"2021-10-05 21:40","market":"us","language":"en","title":"A decade later, Steve Jobs is still paving Apple’s path to success","url":"https://stock-news.laohu8.com/highlight/detail?id=1116662375","media":"macworld","summary":"Time rolls forward, the past recedes, and it all starts to fade, doesn’t it? Ten years ago, Steve Jo","content":"<p>Time rolls forward, the past recedes, and it all starts to fade, doesn’t it? Ten years ago, Steve Jobs died, and at the time Ipondered how he’d be remembered. In the intervening years, his most notable product–Apple itself–has risen to unimaginable levels of power and influence.</p>\n<p>The fact that so much of Apple’s growth has happened since Jobs’s departure hasn’t reduced him at all. It would be relatively easy to argue that the success of Tim Cook’s Apple suggests that, despite everyone’s concern in the late days of 2011, the company actually<i>could</i>go on without Jobs at the helm. But that’s not what anyone thinks. Instead, Jobs is credited for putting Apple on the path that led to it becoming what it is today.</p>\n<p>The 10 years before</p>\n<p>On October 5, 2001, 10 years before Jobs passed away, Apple is busy digging itself out of an enormous hole. Jobs returned to the company with the purchase of NeXT in late 1996, assumed the reins of power in mid-1997, and four years later his big accomplishment is mostly that Apple hasn’t gone out of business yet. Thanks to the iMac G3, the company had a financial lifeline that has allowed it to renovate the rest of the Mac product line, get an entirely new Mac OSout the door, and begin expanding into retail.</p>\n<p>This is a very different Apple than the one that most people remember, an invisible era where Jobs was furiously throwing ideas at the wall to see what would stick. (A server! Acube-shaped Power Mac!) This Apple was not afraid of failure. It wasn’t afraid of looking foolish. It was, in fact, completely embracing the fact that it would need to keep trying and be willing to fail in order to find where it might succeed.</p>\n<p>One of those wild ideas ended up saving the company.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/272cbc070a8abecbfeba42331c92a783\" tg-width=\"1200\" tg-height=\"800\" width=\"100%\" height=\"auto\"><span>Apple had been struggling for years. Then the iPod came along to start a string of successes that made the company what it is today.</span></p>\n<p>Ten years before Steve Jobs died, he and his team were putting the finishing touches on the new product they’d be introducing a couple of weeks later. It was another weird idea that was still worth trying–a digital music player so compact that you could carry a thousand songs with you in your pocket.</p>\n<p>The iMac G3’s sales success might have given Apple a lifeline, but it was the iPod (which has its 20th birthday later this month) that introduced Apple’s brand to countless people who had never,<i>would</i>never consider buying a Mac. And combined with the expanding Apple retail empire–another idea that might have ended in disaster, but didn’t–the iPod turned people on to Apple as a brand, making them consider the Mac as well–and Apple’s fortunes grew.</p>\n<p>From there, of course, Apple was on the path to build the iPhone and the iPad, constructing the core trio of products that drive the company even today.</p>\n<p>The 10 years after</p>\n<p>During Apple’sfinal financial quarter with Jobs as CEO, Apple delivered its best financial quarter ever. The company generated a record $28.6 billion in revenue and a record $7.31 billion in profit. It sold $13.3 billion worth of iPhones, $6 billion worth of iPads, and $5.1 billion worth of Macs.</p>\n<p>Ten years after Jobs left Apple,the resultswere a bit better. Revenue was $81.4 billion, 2.8 times more than the decade-ago quarter. Profit was $21.7 billion, nearly three times the decade-ago total. Apple sold $39.5 billion worth of iPhones (up nearly 3 times), $7.3 billion worth of iPads (up 22 percent), and $8.2 billion worth of Macs (up 61 percent).</p>\n<p>Under Tim Cook’s stewardship, Apple has tripled what it makes in an average quarter. It has grown two major new sources of revenue in wearable products (such as Apple Watch and AirPods) and services. Does Tim Cook deserve credit for this? Given how so many experts were convinced that Apple would be utterly adrift without Steve Jobs at the helm, I certainly think so.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1ff011b19b561e07a75dc6408fdd7251\" tg-width=\"1200\" tg-height=\"800\" width=\"100%\" height=\"auto\"><span>Apple has experienced tremendous success since Steve Jobs’ death. Tim Cook deserves all the credit, just as Jobs is viewed as the one who set it all up.</span></p>\n<p>Just as Apple’s modern corporate culture really owes itself to what Jobs established when he returned to the company in the 1990s, Cook himself was chosen by Jobs as his successor. I think it’s fair to say that Jobs probably saw the trajectory Apple was on and trusted Cook to navigate the company through that growth while also continuing to focus on developing new products and iterating on existing ones.</p>\n<p>So while Cook deserves credit for steering Apple through these waters, Jobs is rightfully viewed as the person who set it all up. The enormous success of Apple in the decade since Jobs died only adds to his legacy.</p>\n<p>But lest we forget, nothing is forever. Apple TV+, a service that Jobs probably wouldn’t have conceived of himself, recently premiered a series based on Isaac Asimov’s “Foundation” book series. “Foundation” is, fundamentally, about one man’s vision of the future–and how one man’s vision is no match for the sweep of history.</p>\n<p>Time does roll forward, and our perceptions of events continue to shift. Events witnessed in person become old stories retold, subject to the limits of our memories and the imperfection of second-hand storytelling. My daughter was born just after the iPod was announced, but before it shipped. She’s about to turn 20. Where does the time go?</p>\n<p>“Those of us who are lucky enough to grow old and rickety (in a way that, cruelly, Steven Paul Jobs was never allowed to) will say that we saw that man stand upon a stage with a giant Apple logo behind him and introduce a new iconic, world-changing product,”I wrote when Jobs died. “In a hundred years, perhaps he will have been reduced to a caricature.” Maybe so. But we should all be so lucky.</p>","source":"lsy1633441374938","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A decade later, Steve Jobs is still paving Apple’s path to success</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA decade later, Steve Jobs is still paving Apple’s path to success\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 21:40 GMT+8 <a href=https://www.macworld.com/article/540956/steve-jobs-apple-path-to-success.html><strong>macworld</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Time rolls forward, the past recedes, and it all starts to fade, doesn’t it? Ten years ago, Steve Jobs died, and at the time Ipondered how he’d be remembered. In the intervening years, his most ...</p>\n\n<a href=\"https://www.macworld.com/article/540956/steve-jobs-apple-path-to-success.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.macworld.com/article/540956/steve-jobs-apple-path-to-success.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116662375","content_text":"Time rolls forward, the past recedes, and it all starts to fade, doesn’t it? Ten years ago, Steve Jobs died, and at the time Ipondered how he’d be remembered. In the intervening years, his most notable product–Apple itself–has risen to unimaginable levels of power and influence.\nThe fact that so much of Apple’s growth has happened since Jobs’s departure hasn’t reduced him at all. It would be relatively easy to argue that the success of Tim Cook’s Apple suggests that, despite everyone’s concern in the late days of 2011, the company actuallycouldgo on without Jobs at the helm. But that’s not what anyone thinks. Instead, Jobs is credited for putting Apple on the path that led to it becoming what it is today.\nThe 10 years before\nOn October 5, 2001, 10 years before Jobs passed away, Apple is busy digging itself out of an enormous hole. Jobs returned to the company with the purchase of NeXT in late 1996, assumed the reins of power in mid-1997, and four years later his big accomplishment is mostly that Apple hasn’t gone out of business yet. Thanks to the iMac G3, the company had a financial lifeline that has allowed it to renovate the rest of the Mac product line, get an entirely new Mac OSout the door, and begin expanding into retail.\nThis is a very different Apple than the one that most people remember, an invisible era where Jobs was furiously throwing ideas at the wall to see what would stick. (A server! Acube-shaped Power Mac!) This Apple was not afraid of failure. It wasn’t afraid of looking foolish. It was, in fact, completely embracing the fact that it would need to keep trying and be willing to fail in order to find where it might succeed.\nOne of those wild ideas ended up saving the company.\nApple had been struggling for years. Then the iPod came along to start a string of successes that made the company what it is today.\nTen years before Steve Jobs died, he and his team were putting the finishing touches on the new product they’d be introducing a couple of weeks later. It was another weird idea that was still worth trying–a digital music player so compact that you could carry a thousand songs with you in your pocket.\nThe iMac G3’s sales success might have given Apple a lifeline, but it was the iPod (which has its 20th birthday later this month) that introduced Apple’s brand to countless people who had never,wouldnever consider buying a Mac. And combined with the expanding Apple retail empire–another idea that might have ended in disaster, but didn’t–the iPod turned people on to Apple as a brand, making them consider the Mac as well–and Apple’s fortunes grew.\nFrom there, of course, Apple was on the path to build the iPhone and the iPad, constructing the core trio of products that drive the company even today.\nThe 10 years after\nDuring Apple’sfinal financial quarter with Jobs as CEO, Apple delivered its best financial quarter ever. The company generated a record $28.6 billion in revenue and a record $7.31 billion in profit. It sold $13.3 billion worth of iPhones, $6 billion worth of iPads, and $5.1 billion worth of Macs.\nTen years after Jobs left Apple,the resultswere a bit better. Revenue was $81.4 billion, 2.8 times more than the decade-ago quarter. Profit was $21.7 billion, nearly three times the decade-ago total. Apple sold $39.5 billion worth of iPhones (up nearly 3 times), $7.3 billion worth of iPads (up 22 percent), and $8.2 billion worth of Macs (up 61 percent).\nUnder Tim Cook’s stewardship, Apple has tripled what it makes in an average quarter. It has grown two major new sources of revenue in wearable products (such as Apple Watch and AirPods) and services. Does Tim Cook deserve credit for this? Given how so many experts were convinced that Apple would be utterly adrift without Steve Jobs at the helm, I certainly think so.\nApple has experienced tremendous success since Steve Jobs’ death. Tim Cook deserves all the credit, just as Jobs is viewed as the one who set it all up.\nJust as Apple’s modern corporate culture really owes itself to what Jobs established when he returned to the company in the 1990s, Cook himself was chosen by Jobs as his successor. I think it’s fair to say that Jobs probably saw the trajectory Apple was on and trusted Cook to navigate the company through that growth while also continuing to focus on developing new products and iterating on existing ones.\nSo while Cook deserves credit for steering Apple through these waters, Jobs is rightfully viewed as the person who set it all up. The enormous success of Apple in the decade since Jobs died only adds to his legacy.\nBut lest we forget, nothing is forever. Apple TV+, a service that Jobs probably wouldn’t have conceived of himself, recently premiered a series based on Isaac Asimov’s “Foundation” book series. “Foundation” is, fundamentally, about one man’s vision of the future–and how one man’s vision is no match for the sweep of history.\nTime does roll forward, and our perceptions of events continue to shift. Events witnessed in person become old stories retold, subject to the limits of our memories and the imperfection of second-hand storytelling. My daughter was born just after the iPod was announced, but before it shipped. She’s about to turn 20. Where does the time go?\n“Those of us who are lucky enough to grow old and rickety (in a way that, cruelly, Steven Paul Jobs was never allowed to) will say that we saw that man stand upon a stage with a giant Apple logo behind him and introduce a new iconic, world-changing product,”I wrote when Jobs died. “In a hundred years, perhaps he will have been reduced to a caricature.” Maybe so. But we should all be so lucky.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":2014,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":830494960,"gmtCreate":1629087685250,"gmtModify":1633687493898,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/830494960","repostId":"2159210869","repostType":4,"repost":{"id":"2159210869","kind":"highlight","pubTimestamp":1629085131,"share":"https://ttm.financial/m/news/2159210869?lang=&edition=full","pubTime":"2021-08-16 11:38","market":"us","language":"en","title":"5 Game-Changing Stocks That Can Turn $250,000 Into $1 Million by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2159210869","media":"Motley Fool","summary":"These innovative companies can generate life-altering returns for patient investors.","content":"<p>Since the stock market bottomed out in March 2020, investors have been treated to a record-breaking bounce-back rally. The widely followed <b>S&P 500</b> has nearly doubled in 16 months, and it's spent the better part of 2021 pushing to <a href=\"https://laohu8.com/S/AONE.U\">one</a> new all-time high after another.</p>\n<p>While some investors might be skittish about putting money to work with the market regularly knocking on the door of new highs, history has shown that, if you're a long-term investor who allows their investment thesis to play out, anytime is a great time to buy high-quality stocks.</p>\n<p>The following five game-changing stocks all offer the potential to turn a sizable amount of cash, say $250,000, into a life-altering amount of money ($1 million) by 2030.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/16d711291c526c90f22832ea8dbaa542\" tg-width=\"700\" tg-height=\"393\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>Don't let anyone tell you that brand-name, mega-cap stocks can't deliver big-time returns for investors. Despite a $236 billion market cap, cloud-based customer relationship management (CRM) software provider <b>Salesforce.com </b>(NYSE:CRM) has all the tools necessary to make a run at a $1 trillion valuation by the end of the decade.</p>\n<p>For those of you wondering, CRM software is used consumer-facing businesses to oversee client relationships, handle service issues, manage online marketing campaigns, and run a variety of predictive analyses, to name a few core functions. Salesforce is the undisputed king of CRM sales. When IDC examined global CRM revenue in the first half of 2020, it found that Salesforce brought in 19.8% of total sales. That was more than its four-closest competitors, combined, and it practically ensures that the company's leading position in this double-digit growth trend remains unmatched.</p>\n<p>Salesforce CEO Marc Benioff has also been a mastermind on the acquisition front. Previous purchases (MuleSoft and Tableau) have expanded its product and service ecosystem and helped to fuel a 29% compound annual sales growth rate over the past decade. The company's most recent acquisition of cloud-based enterprise communications platform <a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a> will serve as a jumping-off point for Salesforce to cross-sell to small-and-medium-sized businesses.</p>\n<p>If all continues to go well, Salesforce will surpass $50 billion in annual sales by fiscal 2026 after reporting $21.3 billion in revenue in fiscal 2021. That's sustainable growth long-term investors can count on.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/32c18ecc95b7f09fe697dc43e18f48db\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>The Original Bark Company</h2>\n<p>On the other end of the spectrum is dog-focused product and service small-cap stock, <b>The Original Bark Company</b> (NYSE:BARK), which is perhaps better known as BarkBox.</p>\n<p>Even though pet expenditures aren't growing as quickly as CRM software on an annual basis, there may not be a more recession-resistant industry than pets. After all, sales data from the American Pet Products Association shows it's been at least a quarter of a century since year-over-year pet spending declined. This year alone, pet owners are forecast to shell out $109.6 billion.</p>\n<p>What makes Bark so intriguing is its subscription-focused operating model. Approximately 90% of its sales are based on a monthly subscription model, with the remainder originating from product placement in over 23,000 retail locations. Not having to maintain brick-and-mortar locations or sit on mountains of inventory means lower overhead costs and a gross margin that's consistently hovered around 60%.</p>\n<p>Furthermore, Bark is leaning on innovation and tech-driven personalization to boost sales. Last year, it introduced Bark Home and Bark Eats. Bark Home is a portal for basic need accessories like leashes and beds, whereas Bark Eats is a subscription service that works with owners to develop a customized dry food diet for their pooch. The potential for add-on sales, along with existing growth opportunities, could triple Bark's revenue by fiscal 2026.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0fcb2293b92cf93aba2597dc9a6facfa\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Lovesac</h2>\n<p>Another game-changing stock that can turn $250,000 into a cool $1 million or more by 2030 is furniture stock <b>Lovesac</b> (NASDAQ:LOVE). And yes, I did just use the words \"game-changing\" and \"furniture stock\" in the same sentence.</p>\n<p>Typically, retailing furniture is a highly cyclical and relatively boring operating model that's dependent on brick-and-mortar retail locations. However, Lovesac is changing up multiple aspects of the furniture industry.</p>\n<p>Arguably the biggest difference between Lovesac and traditional furniture manufacturers and retailers is the product. Almost 85% of Lovesac's revenue is derived from its \"sactionals.\" These are sectional-based modular couches that can be rearranged a countless number of ways to accommodate any livable space. The company's sactionals have approximately 200 different cover choices, which means that buyers shouldn't have any trouble matching Lovesac's modular furniture with the color scheme or theme of their home. And lastly, the yarn used in these covers is made entirely from recycled plastic water bottles. That's functionality, choice, and environmentally friendly products all rolled up into one.</p>\n<p>Were this not enough, the company has dazzled Wall Street with its ability to shift its sales approach during the pandemic. In fiscal 2021, 47% of Lovesac's sales were generated online, with another 7% coming from pop-up showrooms. Having less in the way of overhead and emphasizing direct-to-consumer sales pushed the company to recurring profitability well ahead of Wall Street's forecast.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4cce76d99ddda76b09159b54489063e9\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Jushi Holdings</h2>\n<p>The U.S. cannabis industry should be another source of opportunity for patient growth-seeking investors this decade. By 2030, small-cap marijuana stock <b>Jushi Holdings</b> (OTC:JUSHF) has a good chance to quadruple (or more) in value.</p>\n<p>Jushi's growth story can't be told without noting its focus on limited-license states. More than 80% of the company's revenue this year will likely originate from Pennsylvania, Illinois, and Virginia. The former two states cap how many retail licenses can be issued in aggregate, and to a single business, while Virginia assigns licenses according to jurisdiction. The key point being that these three markets are purposely reining in competition, which will ensure that Jushi has a fair chance to build up its brand and garner a loyal following.</p>\n<p>For such a small pot stock, Jushi hasn't been afraid to put the capital it's raised to work. It's expanded its cultivation potential in Virginia, added to its large retail presence in Pennsylvania, and acquired two dispensaries in California, just since the year began. California is the world's leading marijuana market by annual sales.</p>\n<p>Between 2020 and 2024, Wall Street is looking for Jushi's sales to climb by 1,100% to nearly $1 billion. With the company expected to become profitable on a recurring basis next year, it may well be the biggest bargain in the industry.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/69c8d46ab082fe9b933b958f3354a003\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Sea Limited</h2>\n<p>A final game-changing stock that could generate a life-altering return for investors is Singapore-based <b>Sea Limited</b> (NYSE:SE). What makes Sea such a special company is that it has a trio of rapidly growing operating segments to support its valuation expansion.</p>\n<p>For starters, Sea's gaming division has grown rapidly, and is currently the only one of the three segments generating positive earnings before interest, taxes, depreciation, and amortization (EBITDA). As of the end of March, Sea had close to 649 million active mobile gamers, 12.3% of which were paying customers. Most pay-to-play platforms only average a 2% conversion rate, so this is a phenomenal monetization rate for its mobile game platform.</p>\n<p>Second, Sea has a rapidly expanding e-commerce presence in Southeastern Asia and Brazil. Shopee, as the company's online commerce platform is known, is the most-downloaded shopping app in Southeast Asia. Between a burgeoning middle class and the coronavirus pandemic keeping people in their homes, Shopee saw more gross merchandise value traverse its network in the first three months of 2021 than it did in all of 2018.</p>\n<p>And third, Sea has its relatively new digital financial services operations. Since many of the regions Sea operates in are underbanked, the ability to offer mobile wallet payments could be a game-changer for consumers. The company already has more than 26 million paying users. Altogether, these three segments could quintuple Sea's annual sales over the next four years.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Game-Changing Stocks That Can Turn $250,000 Into $1 Million by 2030</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Game-Changing Stocks That Can Turn $250,000 Into $1 Million by 2030\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-16 11:38 GMT+8 <a href=https://www.fool.com/investing/2021/08/15/5-game-changing-stocks-250000-to-1-million-by-2030/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since the stock market bottomed out in March 2020, investors have been treated to a record-breaking bounce-back rally. The widely followed S&P 500 has nearly doubled in 16 months, and it's spent the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/15/5-game-changing-stocks-250000-to-1-million-by-2030/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LOVE":"Lovesac Co.","BARK":"The Original Bark Corp.","SE":"Sea Ltd","JUSHF":"Jushi Holdings Inc.","CRM":"赛富时"},"source_url":"https://www.fool.com/investing/2021/08/15/5-game-changing-stocks-250000-to-1-million-by-2030/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159210869","content_text":"Since the stock market bottomed out in March 2020, investors have been treated to a record-breaking bounce-back rally. The widely followed S&P 500 has nearly doubled in 16 months, and it's spent the better part of 2021 pushing to one new all-time high after another.\nWhile some investors might be skittish about putting money to work with the market regularly knocking on the door of new highs, history has shown that, if you're a long-term investor who allows their investment thesis to play out, anytime is a great time to buy high-quality stocks.\nThe following five game-changing stocks all offer the potential to turn a sizable amount of cash, say $250,000, into a life-altering amount of money ($1 million) by 2030.\nImage source: Getty Images.\nSalesforce\nDon't let anyone tell you that brand-name, mega-cap stocks can't deliver big-time returns for investors. Despite a $236 billion market cap, cloud-based customer relationship management (CRM) software provider Salesforce.com (NYSE:CRM) has all the tools necessary to make a run at a $1 trillion valuation by the end of the decade.\nFor those of you wondering, CRM software is used consumer-facing businesses to oversee client relationships, handle service issues, manage online marketing campaigns, and run a variety of predictive analyses, to name a few core functions. Salesforce is the undisputed king of CRM sales. When IDC examined global CRM revenue in the first half of 2020, it found that Salesforce brought in 19.8% of total sales. That was more than its four-closest competitors, combined, and it practically ensures that the company's leading position in this double-digit growth trend remains unmatched.\nSalesforce CEO Marc Benioff has also been a mastermind on the acquisition front. Previous purchases (MuleSoft and Tableau) have expanded its product and service ecosystem and helped to fuel a 29% compound annual sales growth rate over the past decade. The company's most recent acquisition of cloud-based enterprise communications platform Slack Technologies will serve as a jumping-off point for Salesforce to cross-sell to small-and-medium-sized businesses.\nIf all continues to go well, Salesforce will surpass $50 billion in annual sales by fiscal 2026 after reporting $21.3 billion in revenue in fiscal 2021. That's sustainable growth long-term investors can count on.\nImage source: Getty Images.\nThe Original Bark Company\nOn the other end of the spectrum is dog-focused product and service small-cap stock, The Original Bark Company (NYSE:BARK), which is perhaps better known as BarkBox.\nEven though pet expenditures aren't growing as quickly as CRM software on an annual basis, there may not be a more recession-resistant industry than pets. After all, sales data from the American Pet Products Association shows it's been at least a quarter of a century since year-over-year pet spending declined. This year alone, pet owners are forecast to shell out $109.6 billion.\nWhat makes Bark so intriguing is its subscription-focused operating model. Approximately 90% of its sales are based on a monthly subscription model, with the remainder originating from product placement in over 23,000 retail locations. Not having to maintain brick-and-mortar locations or sit on mountains of inventory means lower overhead costs and a gross margin that's consistently hovered around 60%.\nFurthermore, Bark is leaning on innovation and tech-driven personalization to boost sales. Last year, it introduced Bark Home and Bark Eats. Bark Home is a portal for basic need accessories like leashes and beds, whereas Bark Eats is a subscription service that works with owners to develop a customized dry food diet for their pooch. The potential for add-on sales, along with existing growth opportunities, could triple Bark's revenue by fiscal 2026.\nImage source: Getty Images.\nLovesac\nAnother game-changing stock that can turn $250,000 into a cool $1 million or more by 2030 is furniture stock Lovesac (NASDAQ:LOVE). And yes, I did just use the words \"game-changing\" and \"furniture stock\" in the same sentence.\nTypically, retailing furniture is a highly cyclical and relatively boring operating model that's dependent on brick-and-mortar retail locations. However, Lovesac is changing up multiple aspects of the furniture industry.\nArguably the biggest difference between Lovesac and traditional furniture manufacturers and retailers is the product. Almost 85% of Lovesac's revenue is derived from its \"sactionals.\" These are sectional-based modular couches that can be rearranged a countless number of ways to accommodate any livable space. The company's sactionals have approximately 200 different cover choices, which means that buyers shouldn't have any trouble matching Lovesac's modular furniture with the color scheme or theme of their home. And lastly, the yarn used in these covers is made entirely from recycled plastic water bottles. That's functionality, choice, and environmentally friendly products all rolled up into one.\nWere this not enough, the company has dazzled Wall Street with its ability to shift its sales approach during the pandemic. In fiscal 2021, 47% of Lovesac's sales were generated online, with another 7% coming from pop-up showrooms. Having less in the way of overhead and emphasizing direct-to-consumer sales pushed the company to recurring profitability well ahead of Wall Street's forecast.\nImage source: Getty Images.\nJushi Holdings\nThe U.S. cannabis industry should be another source of opportunity for patient growth-seeking investors this decade. By 2030, small-cap marijuana stock Jushi Holdings (OTC:JUSHF) has a good chance to quadruple (or more) in value.\nJushi's growth story can't be told without noting its focus on limited-license states. More than 80% of the company's revenue this year will likely originate from Pennsylvania, Illinois, and Virginia. The former two states cap how many retail licenses can be issued in aggregate, and to a single business, while Virginia assigns licenses according to jurisdiction. The key point being that these three markets are purposely reining in competition, which will ensure that Jushi has a fair chance to build up its brand and garner a loyal following.\nFor such a small pot stock, Jushi hasn't been afraid to put the capital it's raised to work. It's expanded its cultivation potential in Virginia, added to its large retail presence in Pennsylvania, and acquired two dispensaries in California, just since the year began. California is the world's leading marijuana market by annual sales.\nBetween 2020 and 2024, Wall Street is looking for Jushi's sales to climb by 1,100% to nearly $1 billion. With the company expected to become profitable on a recurring basis next year, it may well be the biggest bargain in the industry.\nImage source: Getty Images.\nSea Limited\nA final game-changing stock that could generate a life-altering return for investors is Singapore-based Sea Limited (NYSE:SE). What makes Sea such a special company is that it has a trio of rapidly growing operating segments to support its valuation expansion.\nFor starters, Sea's gaming division has grown rapidly, and is currently the only one of the three segments generating positive earnings before interest, taxes, depreciation, and amortization (EBITDA). As of the end of March, Sea had close to 649 million active mobile gamers, 12.3% of which were paying customers. Most pay-to-play platforms only average a 2% conversion rate, so this is a phenomenal monetization rate for its mobile game platform.\nSecond, Sea has a rapidly expanding e-commerce presence in Southeastern Asia and Brazil. Shopee, as the company's online commerce platform is known, is the most-downloaded shopping app in Southeast Asia. Between a burgeoning middle class and the coronavirus pandemic keeping people in their homes, Shopee saw more gross merchandise value traverse its network in the first three months of 2021 than it did in all of 2018.\nAnd third, Sea has its relatively new digital financial services operations. Since many of the regions Sea operates in are underbanked, the ability to offer mobile wallet payments could be a game-changer for consumers. The company already has more than 26 million paying users. Altogether, these three segments could quintuple Sea's annual sales over the next four years.","news_type":1,"symbols_score_info":{"BARK":0.9,"CRM":0.9,"JUSHF":0.9,"LOVE":0.9,"SE":0.9}},"isVote":1,"tweetType":1,"viewCount":1731,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892493015,"gmtCreate":1628680235837,"gmtModify":1633745189737,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892493015","repostId":"2158475046","repostType":4,"repost":{"id":"2158475046","kind":"highlight","pubTimestamp":1628600400,"share":"https://ttm.financial/m/news/2158475046?lang=&edition=full","pubTime":"2021-08-10 21:00","market":"us","language":"en","title":"5 Growth Stocks With 110% to 393% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2158475046","media":"Motley Fool","summary":"Analysts are calling for significant gains in these fast-paced stocks.","content":"<p>For the past nine months, the stock market has been practically unstoppable. The benchmark <b>S&P 500</b> hasn't undergone a single 5% drop, and it's nearly doubled since hitting its bear-market low on March 23, 2020.</p>\n<p>But despite this record-breaking rally, Wall Street still sees value in a number of high-growth stocks. Based on the highest price target issued by a Wall Street investment bank or analyst, the following five growth stocks are expected to return 110% to as much as 393% to shareholders.</p>\n<h2>Coinbase Global: Implied upside of 152%</h2>\n<p>The first rapidly growing stock with abundant upside, at least according to investment firm D.A. Davidson, is cryptocurrency brokerage and ecosystem <b>Coinbase Global</b> (NASDAQ:COIN). If the lofty $650 price target set by D.A. Davidson comes to fruition, Coinbase would deliver gains of 152% to its shareholders, relative to where it closed this past weekend.</p>\n<p>On <a href=\"https://laohu8.com/S/AONE.U\">one</a> hand, revenue and profits have soared for Coinbase. Net revenue in the first quarter catapulted to $1.6 billion from $179 million in the year-ago period, with net income of $771 million, up from $32 million. Growing institutional interest in digital currencies like <b>Bitcoin</b> and <b>Ethereum</b>, along with rapidly rising prices for the Big <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> in crypto, drove investors to the platform.</p>\n<p>On the other hand, the Coinbase operating model has virtually no barriers to entry, and its trading fees are at risk of constantly being undercut by other cryptocurrency exchanges. Additionally, instead of thriving off of innovation, Coinbase is effectively held hostage by external interest in Bitcoin and Ethereum and the price performance of the Big <a href=\"https://laohu8.com/S/TWOA\">Two</a> digital currencies. When Bitcoin declined by 80% following its late 2017 peak, Coinbase's revenue was nearly halved.</p>\n<p>Long story short, while sales growth has been impressive, Coinbase isn't charting its own path to success. Its reliance on external factors makes $650 a target that's unlikely to be reached.</p>\n<h2>Cresco Labs: Implied upside of 160%</h2>\n<p>One industry where you'll find no shortage of aggressive price targets is cannabis -- specifically the U.S. pot industry. If the highest price target assigned by Wall Street of nearly $29 for <b>Cresco Labs</b> (OTC:CRLBF) proves accurate, investors in this marijuana stock could enjoy upside of 160%. And unlike Coinbase, this is a price target that I believe can eventually be achieved.</p>\n<p>Like other multistate operators, Cresco is expanding its retail operations organically and via acquisition. In June, it opened its 33rd dispensary nationally, and it holds enough retail licenses in its back pocket to eventually have closer to four dozen operating dispensaries.</p>\n<p>From a retail perspective, Cresco appears to be focusing its efforts on high-dollar states, as well as those that issue licenses on a limited basis (e.g., Illinois, Ohio, and Pennsylvania). The advantage of limited-license states is they're purposefully reining in competition. That means Cresco will have a genuine opportunity to build up its brands in key markets without the fear of being overrun by a multistate operator with deeper pockets.</p>\n<p>Cresco is also the cannabis industry's leading wholesaler of weed. Even though wholesale cannabis produces weaker margins than retail, Cresco Labs has more than enough volume to make up for it. That's because it holds one of only a handful of cannabis distribution licenses in California. This license gives the company access to more than 575 dispensaries throughout the Golden State.</p>\n<h2>Baidu: Implied upside of 141%</h2>\n<p>In spite of a recent crackdown by the Chinese government on a host of tech stocks, Wall Street remains largely undeterred that China-based internet search giant <b>Baidu</b> (NASDAQ:BIDU) will head higher. In fact, based on the high-water analyst price target of nearly $395, Baidu could offer gains of as much as 141%.</p>\n<p>The most obvious catalyst for Baidu is its domestically dominant internet search engine. According to GlobalStats, Baidu has controlled between 66.9% and 79.9% of all internet search share in China over the trailing 12 months. Just as advertisers line up for placement on <b>Alphabet</b>'s leading internet search engine Google, they're willing to pay big bucks to reach internet users in China.</p>\n<p>Beyond the sustainable double-digit sales growth potential of internet search, Baidu is seeing exceptional early returns from its investment in cloud services and artificial intelligence (AI). Though these ancillary operations only accounted for 21% of first-quarter sales, revenue jumped by 70%. What's more, cloud services and AI offer higher margins, relative to marketing revenue. Over time, we should see these ancillary segments really boost Baidu's cash flow generation.</p>\n<p>While I wouldn't count on $395 anytime soon, I do believe $395 is a reasonable future price target for the fast-growing Baidu.</p>\n<h2><a href=\"https://laohu8.com/S/ICPT\">Intercept Pharmaceuticals</a>: Implied upside of 393%</h2>\n<p>If you're looking for a company with make-or-break opportunity, biotech stock <b>Intercept Pharmaceuticals</b> (NASDAQ:ICPT) might be for you. This polarizing small-cap drug developer with a focus on therapies to treat liver diseases has price targets from Wall Street ranging from as low as $16 to as high as $82. If this upper target comes to fruition, shareholders would nearly quintuple their money.</p>\n<p>The promise and peril for Intercept lies with obeticholic acid (OCA), an experimental treatment for nonalcoholic steatohepatitis (NASH), which affects between 2% and 5% of adults in this country and has no cure. In one respect, OCA met one of its two co-primary endpoints in the phase 3 Regenerate study -- a statistically significant improvement in fibrosis without a worsening of NASH. However, the highest and most-effective dose also led to a large number of cases of pruritus (itching) in trial participants.</p>\n<p>Ultimately, Intercept's top drug candidate received a Complete Response Letter from the Food and Drug Administration. The plan for Intercept is to provide additional safety and trial data, with the goal of resubmitting the application. Even if OCA is approved and targeted at a small subset of the sickest patients, it could offer blockbuster sales potential in this untapped indication.</p>\n<p>The other consideration here is Ocaliva (the brand-name version of OCA) is already approved to treat primary biliary cholangitis and is on track to bring in $325 million to $340 million in sales this year. With an existing safety profile and a modestly growing sales floor, Intercept's risk/reward ratio looks favorable.</p>\n<p><img src=\"https://static.tigerbbs.com/96d1687ba107475c062f0147fa401ff2\" tg-width=\"700\" tg-height=\"375\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>The all-electric Nio EC6 crossover hit showrooms last year. Image source: Nio.</p>\n<h2>Nio: Implied upside of 110%</h2>\n<p>A fifth and final growth stock with serious upside, according to Wall Street, is China-based electric vehicle (EV) manufacturer <b>Nio</b> (NYSE:NIO). If the loftiest price target of more than $92 were to come true, investors would see their shares more than double in value.</p>\n<p>The excitement surrounding Nio has to do with the impending electrification of China's automobiles. The Society of Automotive Engineers of China predicted back in 2018 that half of all vehicles sold in the world's largest auto market would run on alternative energy by 2035. With the EV industry predominantly nascent in China, the door is wide open for multiple companies to gobble up significant share.</p>\n<p>Having resolved any funding concerns with capital raises, the focus now is on Nio's production expansion. Even facing industrywide chip shortages, Nio still managed to deliver almost 21,900 EVs during the second quarter, which was more than double what it delivered in the year-ago period. Assuming chip supply issues can be resolved somewhat soon, Nio's annual EV run-rate output should climb toward 150,000.</p>\n<p>Additionally, Nio is enticing new buyers with its battery-as-a-service program. Enrolling in this monthly fee-based program can lop thousands of dollars off the initial purchase price of a vehicle, all while improving buyer loyalty for Nio.</p>\n<p>A $92 price target might be a bit much for a company that's produced fewer than 118,000 EVs inception. Nevertheless, its execution of late is commendable.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Growth Stocks With 110% to 393% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Growth Stocks With 110% to 393% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 21:00 GMT+8 <a href=https://www.fool.com/investing/2021/08/10/5-growth-stocks-with-110-to-393-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For the past nine months, the stock market has been practically unstoppable. The benchmark S&P 500 hasn't undergone a single 5% drop, and it's nearly doubled since hitting its bear-market low on March...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/10/5-growth-stocks-with-110-to-393-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIDU":"百度","COIN":"Coinbase Global, Inc.","NIO":"蔚来","CRLBF":"Cresco Labs Inc.","ICPT":"Intercept Pharmaceuticals"},"source_url":"https://www.fool.com/investing/2021/08/10/5-growth-stocks-with-110-to-393-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158475046","content_text":"For the past nine months, the stock market has been practically unstoppable. The benchmark S&P 500 hasn't undergone a single 5% drop, and it's nearly doubled since hitting its bear-market low on March 23, 2020.\nBut despite this record-breaking rally, Wall Street still sees value in a number of high-growth stocks. Based on the highest price target issued by a Wall Street investment bank or analyst, the following five growth stocks are expected to return 110% to as much as 393% to shareholders.\nCoinbase Global: Implied upside of 152%\nThe first rapidly growing stock with abundant upside, at least according to investment firm D.A. Davidson, is cryptocurrency brokerage and ecosystem Coinbase Global (NASDAQ:COIN). If the lofty $650 price target set by D.A. Davidson comes to fruition, Coinbase would deliver gains of 152% to its shareholders, relative to where it closed this past weekend.\nOn one hand, revenue and profits have soared for Coinbase. Net revenue in the first quarter catapulted to $1.6 billion from $179 million in the year-ago period, with net income of $771 million, up from $32 million. Growing institutional interest in digital currencies like Bitcoin and Ethereum, along with rapidly rising prices for the Big Two in crypto, drove investors to the platform.\nOn the other hand, the Coinbase operating model has virtually no barriers to entry, and its trading fees are at risk of constantly being undercut by other cryptocurrency exchanges. Additionally, instead of thriving off of innovation, Coinbase is effectively held hostage by external interest in Bitcoin and Ethereum and the price performance of the Big Two digital currencies. When Bitcoin declined by 80% following its late 2017 peak, Coinbase's revenue was nearly halved.\nLong story short, while sales growth has been impressive, Coinbase isn't charting its own path to success. Its reliance on external factors makes $650 a target that's unlikely to be reached.\nCresco Labs: Implied upside of 160%\nOne industry where you'll find no shortage of aggressive price targets is cannabis -- specifically the U.S. pot industry. If the highest price target assigned by Wall Street of nearly $29 for Cresco Labs (OTC:CRLBF) proves accurate, investors in this marijuana stock could enjoy upside of 160%. And unlike Coinbase, this is a price target that I believe can eventually be achieved.\nLike other multistate operators, Cresco is expanding its retail operations organically and via acquisition. In June, it opened its 33rd dispensary nationally, and it holds enough retail licenses in its back pocket to eventually have closer to four dozen operating dispensaries.\nFrom a retail perspective, Cresco appears to be focusing its efforts on high-dollar states, as well as those that issue licenses on a limited basis (e.g., Illinois, Ohio, and Pennsylvania). The advantage of limited-license states is they're purposefully reining in competition. That means Cresco will have a genuine opportunity to build up its brands in key markets without the fear of being overrun by a multistate operator with deeper pockets.\nCresco is also the cannabis industry's leading wholesaler of weed. Even though wholesale cannabis produces weaker margins than retail, Cresco Labs has more than enough volume to make up for it. That's because it holds one of only a handful of cannabis distribution licenses in California. This license gives the company access to more than 575 dispensaries throughout the Golden State.\nBaidu: Implied upside of 141%\nIn spite of a recent crackdown by the Chinese government on a host of tech stocks, Wall Street remains largely undeterred that China-based internet search giant Baidu (NASDAQ:BIDU) will head higher. In fact, based on the high-water analyst price target of nearly $395, Baidu could offer gains of as much as 141%.\nThe most obvious catalyst for Baidu is its domestically dominant internet search engine. According to GlobalStats, Baidu has controlled between 66.9% and 79.9% of all internet search share in China over the trailing 12 months. Just as advertisers line up for placement on Alphabet's leading internet search engine Google, they're willing to pay big bucks to reach internet users in China.\nBeyond the sustainable double-digit sales growth potential of internet search, Baidu is seeing exceptional early returns from its investment in cloud services and artificial intelligence (AI). Though these ancillary operations only accounted for 21% of first-quarter sales, revenue jumped by 70%. What's more, cloud services and AI offer higher margins, relative to marketing revenue. Over time, we should see these ancillary segments really boost Baidu's cash flow generation.\nWhile I wouldn't count on $395 anytime soon, I do believe $395 is a reasonable future price target for the fast-growing Baidu.\nIntercept Pharmaceuticals: Implied upside of 393%\nIf you're looking for a company with make-or-break opportunity, biotech stock Intercept Pharmaceuticals (NASDAQ:ICPT) might be for you. This polarizing small-cap drug developer with a focus on therapies to treat liver diseases has price targets from Wall Street ranging from as low as $16 to as high as $82. If this upper target comes to fruition, shareholders would nearly quintuple their money.\nThe promise and peril for Intercept lies with obeticholic acid (OCA), an experimental treatment for nonalcoholic steatohepatitis (NASH), which affects between 2% and 5% of adults in this country and has no cure. In one respect, OCA met one of its two co-primary endpoints in the phase 3 Regenerate study -- a statistically significant improvement in fibrosis without a worsening of NASH. However, the highest and most-effective dose also led to a large number of cases of pruritus (itching) in trial participants.\nUltimately, Intercept's top drug candidate received a Complete Response Letter from the Food and Drug Administration. The plan for Intercept is to provide additional safety and trial data, with the goal of resubmitting the application. Even if OCA is approved and targeted at a small subset of the sickest patients, it could offer blockbuster sales potential in this untapped indication.\nThe other consideration here is Ocaliva (the brand-name version of OCA) is already approved to treat primary biliary cholangitis and is on track to bring in $325 million to $340 million in sales this year. With an existing safety profile and a modestly growing sales floor, Intercept's risk/reward ratio looks favorable.\n\nThe all-electric Nio EC6 crossover hit showrooms last year. Image source: Nio.\nNio: Implied upside of 110%\nA fifth and final growth stock with serious upside, according to Wall Street, is China-based electric vehicle (EV) manufacturer Nio (NYSE:NIO). If the loftiest price target of more than $92 were to come true, investors would see their shares more than double in value.\nThe excitement surrounding Nio has to do with the impending electrification of China's automobiles. The Society of Automotive Engineers of China predicted back in 2018 that half of all vehicles sold in the world's largest auto market would run on alternative energy by 2035. With the EV industry predominantly nascent in China, the door is wide open for multiple companies to gobble up significant share.\nHaving resolved any funding concerns with capital raises, the focus now is on Nio's production expansion. Even facing industrywide chip shortages, Nio still managed to deliver almost 21,900 EVs during the second quarter, which was more than double what it delivered in the year-ago period. Assuming chip supply issues can be resolved somewhat soon, Nio's annual EV run-rate output should climb toward 150,000.\nAdditionally, Nio is enticing new buyers with its battery-as-a-service program. Enrolling in this monthly fee-based program can lop thousands of dollars off the initial purchase price of a vehicle, all while improving buyer loyalty for Nio.\nA $92 price target might be a bit much for a company that's produced fewer than 118,000 EVs inception. Nevertheless, its execution of late is commendable.","news_type":1,"symbols_score_info":{"BIDU":0.9,"COIN":0.9,"CRLBF":0.9,"ICPT":0.9,"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":743,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892499260,"gmtCreate":1628680227450,"gmtModify":1633745189960,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892499260","repostId":"2158475046","repostType":4,"repost":{"id":"2158475046","kind":"highlight","pubTimestamp":1628600400,"share":"https://ttm.financial/m/news/2158475046?lang=&edition=full","pubTime":"2021-08-10 21:00","market":"us","language":"en","title":"5 Growth Stocks With 110% to 393% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2158475046","media":"Motley Fool","summary":"Analysts are calling for significant gains in these fast-paced stocks.","content":"<p>For the past nine months, the stock market has been practically unstoppable. The benchmark <b>S&P 500</b> hasn't undergone a single 5% drop, and it's nearly doubled since hitting its bear-market low on March 23, 2020.</p>\n<p>But despite this record-breaking rally, Wall Street still sees value in a number of high-growth stocks. Based on the highest price target issued by a Wall Street investment bank or analyst, the following five growth stocks are expected to return 110% to as much as 393% to shareholders.</p>\n<h2>Coinbase Global: Implied upside of 152%</h2>\n<p>The first rapidly growing stock with abundant upside, at least according to investment firm D.A. Davidson, is cryptocurrency brokerage and ecosystem <b>Coinbase Global</b> (NASDAQ:COIN). If the lofty $650 price target set by D.A. Davidson comes to fruition, Coinbase would deliver gains of 152% to its shareholders, relative to where it closed this past weekend.</p>\n<p>On <a href=\"https://laohu8.com/S/AONE.U\">one</a> hand, revenue and profits have soared for Coinbase. Net revenue in the first quarter catapulted to $1.6 billion from $179 million in the year-ago period, with net income of $771 million, up from $32 million. Growing institutional interest in digital currencies like <b>Bitcoin</b> and <b>Ethereum</b>, along with rapidly rising prices for the Big <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> in crypto, drove investors to the platform.</p>\n<p>On the other hand, the Coinbase operating model has virtually no barriers to entry, and its trading fees are at risk of constantly being undercut by other cryptocurrency exchanges. Additionally, instead of thriving off of innovation, Coinbase is effectively held hostage by external interest in Bitcoin and Ethereum and the price performance of the Big <a href=\"https://laohu8.com/S/TWOA\">Two</a> digital currencies. When Bitcoin declined by 80% following its late 2017 peak, Coinbase's revenue was nearly halved.</p>\n<p>Long story short, while sales growth has been impressive, Coinbase isn't charting its own path to success. Its reliance on external factors makes $650 a target that's unlikely to be reached.</p>\n<h2>Cresco Labs: Implied upside of 160%</h2>\n<p>One industry where you'll find no shortage of aggressive price targets is cannabis -- specifically the U.S. pot industry. If the highest price target assigned by Wall Street of nearly $29 for <b>Cresco Labs</b> (OTC:CRLBF) proves accurate, investors in this marijuana stock could enjoy upside of 160%. And unlike Coinbase, this is a price target that I believe can eventually be achieved.</p>\n<p>Like other multistate operators, Cresco is expanding its retail operations organically and via acquisition. In June, it opened its 33rd dispensary nationally, and it holds enough retail licenses in its back pocket to eventually have closer to four dozen operating dispensaries.</p>\n<p>From a retail perspective, Cresco appears to be focusing its efforts on high-dollar states, as well as those that issue licenses on a limited basis (e.g., Illinois, Ohio, and Pennsylvania). The advantage of limited-license states is they're purposefully reining in competition. That means Cresco will have a genuine opportunity to build up its brands in key markets without the fear of being overrun by a multistate operator with deeper pockets.</p>\n<p>Cresco is also the cannabis industry's leading wholesaler of weed. Even though wholesale cannabis produces weaker margins than retail, Cresco Labs has more than enough volume to make up for it. That's because it holds one of only a handful of cannabis distribution licenses in California. This license gives the company access to more than 575 dispensaries throughout the Golden State.</p>\n<h2>Baidu: Implied upside of 141%</h2>\n<p>In spite of a recent crackdown by the Chinese government on a host of tech stocks, Wall Street remains largely undeterred that China-based internet search giant <b>Baidu</b> (NASDAQ:BIDU) will head higher. In fact, based on the high-water analyst price target of nearly $395, Baidu could offer gains of as much as 141%.</p>\n<p>The most obvious catalyst for Baidu is its domestically dominant internet search engine. According to GlobalStats, Baidu has controlled between 66.9% and 79.9% of all internet search share in China over the trailing 12 months. Just as advertisers line up for placement on <b>Alphabet</b>'s leading internet search engine Google, they're willing to pay big bucks to reach internet users in China.</p>\n<p>Beyond the sustainable double-digit sales growth potential of internet search, Baidu is seeing exceptional early returns from its investment in cloud services and artificial intelligence (AI). Though these ancillary operations only accounted for 21% of first-quarter sales, revenue jumped by 70%. What's more, cloud services and AI offer higher margins, relative to marketing revenue. Over time, we should see these ancillary segments really boost Baidu's cash flow generation.</p>\n<p>While I wouldn't count on $395 anytime soon, I do believe $395 is a reasonable future price target for the fast-growing Baidu.</p>\n<h2><a href=\"https://laohu8.com/S/ICPT\">Intercept Pharmaceuticals</a>: Implied upside of 393%</h2>\n<p>If you're looking for a company with make-or-break opportunity, biotech stock <b>Intercept Pharmaceuticals</b> (NASDAQ:ICPT) might be for you. This polarizing small-cap drug developer with a focus on therapies to treat liver diseases has price targets from Wall Street ranging from as low as $16 to as high as $82. If this upper target comes to fruition, shareholders would nearly quintuple their money.</p>\n<p>The promise and peril for Intercept lies with obeticholic acid (OCA), an experimental treatment for nonalcoholic steatohepatitis (NASH), which affects between 2% and 5% of adults in this country and has no cure. In one respect, OCA met one of its two co-primary endpoints in the phase 3 Regenerate study -- a statistically significant improvement in fibrosis without a worsening of NASH. However, the highest and most-effective dose also led to a large number of cases of pruritus (itching) in trial participants.</p>\n<p>Ultimately, Intercept's top drug candidate received a Complete Response Letter from the Food and Drug Administration. The plan for Intercept is to provide additional safety and trial data, with the goal of resubmitting the application. Even if OCA is approved and targeted at a small subset of the sickest patients, it could offer blockbuster sales potential in this untapped indication.</p>\n<p>The other consideration here is Ocaliva (the brand-name version of OCA) is already approved to treat primary biliary cholangitis and is on track to bring in $325 million to $340 million in sales this year. With an existing safety profile and a modestly growing sales floor, Intercept's risk/reward ratio looks favorable.</p>\n<p><img src=\"https://static.tigerbbs.com/96d1687ba107475c062f0147fa401ff2\" tg-width=\"700\" tg-height=\"375\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>The all-electric Nio EC6 crossover hit showrooms last year. Image source: Nio.</p>\n<h2>Nio: Implied upside of 110%</h2>\n<p>A fifth and final growth stock with serious upside, according to Wall Street, is China-based electric vehicle (EV) manufacturer <b>Nio</b> (NYSE:NIO). If the loftiest price target of more than $92 were to come true, investors would see their shares more than double in value.</p>\n<p>The excitement surrounding Nio has to do with the impending electrification of China's automobiles. The Society of Automotive Engineers of China predicted back in 2018 that half of all vehicles sold in the world's largest auto market would run on alternative energy by 2035. With the EV industry predominantly nascent in China, the door is wide open for multiple companies to gobble up significant share.</p>\n<p>Having resolved any funding concerns with capital raises, the focus now is on Nio's production expansion. Even facing industrywide chip shortages, Nio still managed to deliver almost 21,900 EVs during the second quarter, which was more than double what it delivered in the year-ago period. Assuming chip supply issues can be resolved somewhat soon, Nio's annual EV run-rate output should climb toward 150,000.</p>\n<p>Additionally, Nio is enticing new buyers with its battery-as-a-service program. Enrolling in this monthly fee-based program can lop thousands of dollars off the initial purchase price of a vehicle, all while improving buyer loyalty for Nio.</p>\n<p>A $92 price target might be a bit much for a company that's produced fewer than 118,000 EVs inception. Nevertheless, its execution of late is commendable.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Growth Stocks With 110% to 393% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Growth Stocks With 110% to 393% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 21:00 GMT+8 <a href=https://www.fool.com/investing/2021/08/10/5-growth-stocks-with-110-to-393-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For the past nine months, the stock market has been practically unstoppable. The benchmark S&P 500 hasn't undergone a single 5% drop, and it's nearly doubled since hitting its bear-market low on March...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/10/5-growth-stocks-with-110-to-393-upside-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIDU":"百度","COIN":"Coinbase Global, Inc.","NIO":"蔚来","CRLBF":"Cresco Labs Inc.","ICPT":"Intercept Pharmaceuticals"},"source_url":"https://www.fool.com/investing/2021/08/10/5-growth-stocks-with-110-to-393-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158475046","content_text":"For the past nine months, the stock market has been practically unstoppable. The benchmark S&P 500 hasn't undergone a single 5% drop, and it's nearly doubled since hitting its bear-market low on March 23, 2020.\nBut despite this record-breaking rally, Wall Street still sees value in a number of high-growth stocks. Based on the highest price target issued by a Wall Street investment bank or analyst, the following five growth stocks are expected to return 110% to as much as 393% to shareholders.\nCoinbase Global: Implied upside of 152%\nThe first rapidly growing stock with abundant upside, at least according to investment firm D.A. Davidson, is cryptocurrency brokerage and ecosystem Coinbase Global (NASDAQ:COIN). If the lofty $650 price target set by D.A. Davidson comes to fruition, Coinbase would deliver gains of 152% to its shareholders, relative to where it closed this past weekend.\nOn one hand, revenue and profits have soared for Coinbase. Net revenue in the first quarter catapulted to $1.6 billion from $179 million in the year-ago period, with net income of $771 million, up from $32 million. Growing institutional interest in digital currencies like Bitcoin and Ethereum, along with rapidly rising prices for the Big Two in crypto, drove investors to the platform.\nOn the other hand, the Coinbase operating model has virtually no barriers to entry, and its trading fees are at risk of constantly being undercut by other cryptocurrency exchanges. Additionally, instead of thriving off of innovation, Coinbase is effectively held hostage by external interest in Bitcoin and Ethereum and the price performance of the Big Two digital currencies. When Bitcoin declined by 80% following its late 2017 peak, Coinbase's revenue was nearly halved.\nLong story short, while sales growth has been impressive, Coinbase isn't charting its own path to success. Its reliance on external factors makes $650 a target that's unlikely to be reached.\nCresco Labs: Implied upside of 160%\nOne industry where you'll find no shortage of aggressive price targets is cannabis -- specifically the U.S. pot industry. If the highest price target assigned by Wall Street of nearly $29 for Cresco Labs (OTC:CRLBF) proves accurate, investors in this marijuana stock could enjoy upside of 160%. And unlike Coinbase, this is a price target that I believe can eventually be achieved.\nLike other multistate operators, Cresco is expanding its retail operations organically and via acquisition. In June, it opened its 33rd dispensary nationally, and it holds enough retail licenses in its back pocket to eventually have closer to four dozen operating dispensaries.\nFrom a retail perspective, Cresco appears to be focusing its efforts on high-dollar states, as well as those that issue licenses on a limited basis (e.g., Illinois, Ohio, and Pennsylvania). The advantage of limited-license states is they're purposefully reining in competition. That means Cresco will have a genuine opportunity to build up its brands in key markets without the fear of being overrun by a multistate operator with deeper pockets.\nCresco is also the cannabis industry's leading wholesaler of weed. Even though wholesale cannabis produces weaker margins than retail, Cresco Labs has more than enough volume to make up for it. That's because it holds one of only a handful of cannabis distribution licenses in California. This license gives the company access to more than 575 dispensaries throughout the Golden State.\nBaidu: Implied upside of 141%\nIn spite of a recent crackdown by the Chinese government on a host of tech stocks, Wall Street remains largely undeterred that China-based internet search giant Baidu (NASDAQ:BIDU) will head higher. In fact, based on the high-water analyst price target of nearly $395, Baidu could offer gains of as much as 141%.\nThe most obvious catalyst for Baidu is its domestically dominant internet search engine. According to GlobalStats, Baidu has controlled between 66.9% and 79.9% of all internet search share in China over the trailing 12 months. Just as advertisers line up for placement on Alphabet's leading internet search engine Google, they're willing to pay big bucks to reach internet users in China.\nBeyond the sustainable double-digit sales growth potential of internet search, Baidu is seeing exceptional early returns from its investment in cloud services and artificial intelligence (AI). Though these ancillary operations only accounted for 21% of first-quarter sales, revenue jumped by 70%. What's more, cloud services and AI offer higher margins, relative to marketing revenue. Over time, we should see these ancillary segments really boost Baidu's cash flow generation.\nWhile I wouldn't count on $395 anytime soon, I do believe $395 is a reasonable future price target for the fast-growing Baidu.\nIntercept Pharmaceuticals: Implied upside of 393%\nIf you're looking for a company with make-or-break opportunity, biotech stock Intercept Pharmaceuticals (NASDAQ:ICPT) might be for you. This polarizing small-cap drug developer with a focus on therapies to treat liver diseases has price targets from Wall Street ranging from as low as $16 to as high as $82. If this upper target comes to fruition, shareholders would nearly quintuple their money.\nThe promise and peril for Intercept lies with obeticholic acid (OCA), an experimental treatment for nonalcoholic steatohepatitis (NASH), which affects between 2% and 5% of adults in this country and has no cure. In one respect, OCA met one of its two co-primary endpoints in the phase 3 Regenerate study -- a statistically significant improvement in fibrosis without a worsening of NASH. However, the highest and most-effective dose also led to a large number of cases of pruritus (itching) in trial participants.\nUltimately, Intercept's top drug candidate received a Complete Response Letter from the Food and Drug Administration. The plan for Intercept is to provide additional safety and trial data, with the goal of resubmitting the application. Even if OCA is approved and targeted at a small subset of the sickest patients, it could offer blockbuster sales potential in this untapped indication.\nThe other consideration here is Ocaliva (the brand-name version of OCA) is already approved to treat primary biliary cholangitis and is on track to bring in $325 million to $340 million in sales this year. With an existing safety profile and a modestly growing sales floor, Intercept's risk/reward ratio looks favorable.\n\nThe all-electric Nio EC6 crossover hit showrooms last year. Image source: Nio.\nNio: Implied upside of 110%\nA fifth and final growth stock with serious upside, according to Wall Street, is China-based electric vehicle (EV) manufacturer Nio (NYSE:NIO). If the loftiest price target of more than $92 were to come true, investors would see their shares more than double in value.\nThe excitement surrounding Nio has to do with the impending electrification of China's automobiles. The Society of Automotive Engineers of China predicted back in 2018 that half of all vehicles sold in the world's largest auto market would run on alternative energy by 2035. With the EV industry predominantly nascent in China, the door is wide open for multiple companies to gobble up significant share.\nHaving resolved any funding concerns with capital raises, the focus now is on Nio's production expansion. Even facing industrywide chip shortages, Nio still managed to deliver almost 21,900 EVs during the second quarter, which was more than double what it delivered in the year-ago period. Assuming chip supply issues can be resolved somewhat soon, Nio's annual EV run-rate output should climb toward 150,000.\nAdditionally, Nio is enticing new buyers with its battery-as-a-service program. Enrolling in this monthly fee-based program can lop thousands of dollars off the initial purchase price of a vehicle, all while improving buyer loyalty for Nio.\nA $92 price target might be a bit much for a company that's produced fewer than 118,000 EVs inception. Nevertheless, its execution of late is commendable.","news_type":1,"symbols_score_info":{"BIDU":0.9,"COIN":0.9,"CRLBF":0.9,"ICPT":0.9,"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":1449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893376742,"gmtCreate":1628241892486,"gmtModify":1633752310766,"author":{"id":"3583727724427055","authorId":"3583727724427055","name":"Aaronnz","avatar":"https://static.tigerbbs.com/081382b8819d97b743c11f71bcb95f0b","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583727724427055","idStr":"3583727724427055"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/893376742","repostId":"2157469137","repostType":4,"repost":{"id":"2157469137","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628240079,"share":"https://ttm.financial/m/news/2157469137?lang=&edition=full","pubTime":"2021-08-06 16:54","market":"hk","language":"en","title":"Hong Kong shares slip as virus, regulatory concerns weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=2157469137","media":"Reuters","summary":"Hang Seng index ends down 0.1%.\nChina Enterprises index HSCE falls 0.25%.\nProperty sector down 0.6%;","content":"<ul>\n <li>Hang Seng index ends down 0.1%.</li>\n <li>China Enterprises index HSCE falls 0.25%.</li>\n <li>Property sector down 0.6%; Evergrande slumps on downgrade.</li>\n</ul>\n<p>Aug 6 (Reuters) - Hong Kong's Hang Seng Index closed lower on Friday, hit by concerns over tightening government regulations and rising COVID-19 cases in China, even as southbound inflows from mainland investors offered support. ** At the close of trade, the Hang Seng index was down 25.29 points, or 0.1%, at 26,179.40, though it finished up 0.84% for the week. The Hang Seng China Enterprises index fell 0.25% to 9,273.55.</p>\n<p>The drop came as China on Friday reported its highest daily count for new coronavirus infections in its current outbreak. The rise in cases has fuelled concern about the outlook for China's uneven economic recovery.</p>\n<p>The sub-index of the Hang Seng tracking healthcare firms fell 2.26%, as WuXi Biologics (Cayman) Inc dropped 4.85%, making it the biggest loser on the Hang Seng.</p>\n<p>The financial sector edged 0.08% lower and the property sector dipped 0.6%.</p>\n<p>Shares of highly indebted property developer <a href=\"https://laohu8.com/S/EGRNF\">China Evergrande Group</a> slumped 4.59% after rating agency S&P Global downgraded the credit ratings for Evergrande and some subsidiaries.</p>\n<p>China's main Shanghai Composite index closed down 0.24% at 3,458.23, while the blue-chip CSI300 index ended down 0.55%.</p>\n<p>Around the region, MSCI's Asia ex-Japan stock index was weaker by 0.21%, while Japan's Nikkei index closed up 0.33%.</p>\n<p>Trading was relatively thin, with about 1.56 billion Hang Seng index shares changing hands, roughly 72.5% of the market's 30-day moving average of 2.15 billion shares a day and down from 1.70 billion on Thursday.</p>\n<p>But mainland investors were net buyers on the day. Refinitiv data showed flows from mainland investors through the Southbound leg of the Bond Connect programme topped HK$7 billion ($900.21 million).</p>\n<p>($1 = 7.7760 Hong Kong dollars)</p>\n<p>(Reporting by the Shanghai Newsroom; Editing by Subhranshu Sahu)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong shares slip as virus, regulatory concerns weigh</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong shares slip as virus, regulatory concerns weigh\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-06 16:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Hang Seng index ends down 0.1%.</li>\n <li>China Enterprises index HSCE falls 0.25%.</li>\n <li>Property sector down 0.6%; Evergrande slumps on downgrade.</li>\n</ul>\n<p>Aug 6 (Reuters) - Hong Kong's Hang Seng Index closed lower on Friday, hit by concerns over tightening government regulations and rising COVID-19 cases in China, even as southbound inflows from mainland investors offered support. ** At the close of trade, the Hang Seng index was down 25.29 points, or 0.1%, at 26,179.40, though it finished up 0.84% for the week. The Hang Seng China Enterprises index fell 0.25% to 9,273.55.</p>\n<p>The drop came as China on Friday reported its highest daily count for new coronavirus infections in its current outbreak. The rise in cases has fuelled concern about the outlook for China's uneven economic recovery.</p>\n<p>The sub-index of the Hang Seng tracking healthcare firms fell 2.26%, as WuXi Biologics (Cayman) Inc dropped 4.85%, making it the biggest loser on the Hang Seng.</p>\n<p>The financial sector edged 0.08% lower and the property sector dipped 0.6%.</p>\n<p>Shares of highly indebted property developer <a href=\"https://laohu8.com/S/EGRNF\">China Evergrande Group</a> slumped 4.59% after rating agency S&P Global downgraded the credit ratings for Evergrande and some subsidiaries.</p>\n<p>China's main Shanghai Composite index closed down 0.24% at 3,458.23, while the blue-chip CSI300 index ended down 0.55%.</p>\n<p>Around the region, MSCI's Asia ex-Japan stock index was weaker by 0.21%, while Japan's Nikkei index closed up 0.33%.</p>\n<p>Trading was relatively thin, with about 1.56 billion Hang Seng index shares changing hands, roughly 72.5% of the market's 30-day moving average of 2.15 billion shares a day and down from 1.70 billion on Thursday.</p>\n<p>But mainland investors were net buyers on the day. Refinitiv data showed flows from mainland investors through the Southbound leg of the Bond Connect programme topped HK$7 billion ($900.21 million).</p>\n<p>($1 = 7.7760 Hong Kong dollars)</p>\n<p>(Reporting by the Shanghai Newsroom; Editing by Subhranshu Sahu)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157469137","content_text":"Hang Seng index ends down 0.1%.\nChina Enterprises index HSCE falls 0.25%.\nProperty sector down 0.6%; Evergrande slumps on downgrade.\n\nAug 6 (Reuters) - Hong Kong's Hang Seng Index closed lower on Friday, hit by concerns over tightening government regulations and rising COVID-19 cases in China, even as southbound inflows from mainland investors offered support. ** At the close of trade, the Hang Seng index was down 25.29 points, or 0.1%, at 26,179.40, though it finished up 0.84% for the week. The Hang Seng China Enterprises index fell 0.25% to 9,273.55.\nThe drop came as China on Friday reported its highest daily count for new coronavirus infections in its current outbreak. The rise in cases has fuelled concern about the outlook for China's uneven economic recovery.\nThe sub-index of the Hang Seng tracking healthcare firms fell 2.26%, as WuXi Biologics (Cayman) Inc dropped 4.85%, making it the biggest loser on the Hang Seng.\nThe financial sector edged 0.08% lower and the property sector dipped 0.6%.\nShares of highly indebted property developer China Evergrande Group slumped 4.59% after rating agency S&P Global downgraded the credit ratings for Evergrande and some subsidiaries.\nChina's main Shanghai Composite index closed down 0.24% at 3,458.23, while the blue-chip CSI300 index ended down 0.55%.\nAround the region, MSCI's Asia ex-Japan stock index was weaker by 0.21%, while Japan's Nikkei index closed up 0.33%.\nTrading was relatively thin, with about 1.56 billion Hang Seng index shares changing hands, roughly 72.5% of the market's 30-day moving average of 2.15 billion shares a day and down from 1.70 billion on Thursday.\nBut mainland investors were net buyers on the day. Refinitiv data showed flows from mainland investors through the Southbound leg of the Bond Connect programme topped HK$7 billion ($900.21 million).\n($1 = 7.7760 Hong Kong dollars)\n(Reporting by the Shanghai Newsroom; Editing by Subhranshu Sahu)","news_type":1,"symbols_score_info":{"HSI":0.9}},"isVote":1,"tweetType":1,"viewCount":993,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}